<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">FEMS Microbiol Rev</journal-id>
<journal-id journal-id-type="iso-abbrev">FEMS Microbiol. Rev</journal-id>
<journal-id journal-id-type="publisher-id">femsre</journal-id>
<journal-title-group>
<journal-title>FEMS Microbiology Reviews</journal-title>
</journal-title-group>
<issn pub-type="ppub">0168-6445</issn>
<issn pub-type="epub">1574-6976</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32319522</article-id>
<article-id pub-id-type="pmc">7326374</article-id>
<article-id pub-id-type="doi">10.1093/femsre/fuaa010</article-id>
<article-id pub-id-type="publisher-id">fuaa010</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
<subj-group subj-group-type="category-taxonomy-collection">
<subject>AcademicSubjects/SCI00010</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Insights into the reason of Human-Residential Bifidobacteria (HRB) being the natural inhabitants of the human gut and their potential health-promoting benefits</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wong</surname>
<given-names>Chyn Boon</given-names>
</name>
<aff>
<institution>Next Generation Science Institute, Morinaga Milk Industry Co., Ltd.</institution>, 5-1-83, Higashihara, Zama, Kanagawa, 252–8583 <country country="JP">Japan</country></aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Odamaki</surname>
<given-names>Toshitaka</given-names>
</name>
<aff>
<institution>Next Generation Science Institute, Morinaga Milk Industry Co., Ltd.</institution>, 5-1-83, Higashihara, Zama, Kanagawa, 252–8583 <country country="JP">Japan</country></aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Jin-zhong</given-names>
</name>
<!--<email>j_xiao@morinagamilk.co.jp</email>-->
<aff>
<institution>Next Generation Science Institute, Morinaga Milk Industry Co., Ltd.</institution>, 5-1-83, Higashihara, Zama, Kanagawa, 252–8583 <country country="JP">Japan</country></aff>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><bold>Corresponding author:</bold> Next Generation Science Institute, Morinaga Milk Industry Co., Ltd., 5-1-83, Higashihara, Zama, Kanagawa, 252–8583 Japan. Tel: +81-46(252)3064; Fax: +81-46(252)3077; E-mail: <email>j_xiao@morinagamilk.co.jp</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<month>5</month>
<year>2020</year>
</pub-date>
<pub-date iso-8601-date="2020-04-22" pub-type="epub">
<day>22</day>
<month>4</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>22</day>
<month>4</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>44</volume>
<issue>3</issue>
<fpage>369</fpage>
<lpage>385</lpage>
<history>
<date date-type="received">
<day>08</day>
<month>2</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>4</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© FEMS 2020.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri xlink:href="fuaa010.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>Members of <italic>Bifidobacterium</italic> are among the first microbes to colonise the human gut, and certain species are recognised as the natural resident of human gut microbiota. Their presence in the human gut has been associated with health-promoting benefits and reduced abundance of this genus is linked with several diseases. Bifidobacterial species are assumed to have coevolved with their hosts and include members that are naturally present in the human gut, thus recognised as Human-Residential Bifidobacteria (HRB). The physiological functions of these bacteria and the reasons why they occur in and how they adapt to the human gut are of immense significance. In this review, we provide an overview of the biology of bifidobacteria as members of the human gut microbiota and address factors that contribute to the preponderance of HRB in the human gut. We highlight some of the important genetic attributes and core physiological traits of these bacteria that may explain their adaptive advantages, ecological fitness, and competitiveness in the human gut. This review will help to widen our understanding of one of the most important human commensal bacteria and shed light on the practical consideration for selecting bifidobacterial strains as human probiotics.</p>
</abstract>
<abstract abstract-type="teaser">
<p>Bifidobacterial species that ubiquitously encounter in the human host, collectively known as the Human-Residential Bifidobacteria (HRB), possess unique genetic elements and superior physiological functions that contribute to their ecological fitness and competitiveness, and they are thus more beneficial to humans.</p>
</abstract>
<kwd-group kwd-group-type="keywords">
<kwd>bifidobacteria</kwd>
<kwd>human health</kwd>
<kwd>natural inhabitants</kwd>
<kwd>physiological properties</kwd>
<kwd>genetic adaptation</kwd>
<kwd>ecological fitness</kwd>
</kwd-group>
<counts>
<page-count count="17"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<title>INTRODUCTION</title>
<p>Members of the genus <italic>Bifidobacterium</italic> are of substantial importance due to their purported health-promoting effects in human across their lifespan (O'Callaghan and van Sinderen <xref ref-type="bibr" rid="bib108">2016</xref>). Their presence in the human gastrointestinal tract is often associated with health benefits including the production of metabolites such as short-chain fatty acids and vitamins, immune system development and prevention of gut disorders (O'Callaghan and van Sinderen <xref ref-type="bibr" rid="bib108">2016</xref>). Recent advances in bifidobacterial research reveal that bifidobacterial strains have coevolved with their hosts and many physiological characteristics can be residential-origin dependent (Lamendella <italic>et al</italic>. <xref ref-type="bibr" rid="bib77">2008</xref>; Sun <italic>et al</italic>. <xref ref-type="bibr" rid="bib164">2015</xref>; Wong <italic>et al</italic>. <xref ref-type="bibr" rid="bib190">2018</xref>; Zou <italic>et al</italic>. <xref ref-type="bibr" rid="bib196">2019</xref>; Rodriguez and Martiny <xref ref-type="bibr" rid="bib134">2020</xref>). In this regard, some species of bifidobacteria have been identified as the natural inhabitants of the human host (Wong <italic>et al</italic>. <xref ref-type="bibr" rid="bib190">2018</xref>). Nevertheless, the reason why bifidobacterial species reside in the human gut across the life course, their adaptation and survival in the harsh environment of the human gastrointestinal tract and their impact on human health remain elusive. Thus, exploration of their human niche-specific adaptations and functional traits as members of human gut microbiota is of utmost significance.</p>
<p>This review aims at providing an overview of the ecological fitness of the bifidobacterial species that are commonly present in the human gut and elucidate how this bacterial group contribute to human health. Here we summarise current evidence on the colonisation, genetic adaptation and physiological characteristics of the human gut commensal bifidobacteria and address their roles as members of human gut microbiota. An increased understanding of the physiological attributes of this genus and their functions in the human host, which are of immense industrial value, will aid the selection of probiotic strains for human use.</p>
</sec>
<sec id="sec2">
<title>COLONISATION OF BIFIDOBACTERIA IN THE HUMAN GUT</title>
<p>
<italic>Bifidobacterium</italic> is one of the most abundant bacterial genera present in the healthy infant gut (Favier <italic>et al</italic>. <xref ref-type="bibr" rid="bib41">2002</xref>; Odamaki <italic>et al</italic>. <xref ref-type="bibr" rid="bib115">2016</xref>). The abundance of this genus in the human gastrointestinal tract substantially decrease after weaning and continue to decrease with age (Yatsunenko <italic>et al</italic>. <xref ref-type="bibr" rid="bib195">2012</xref>; Kato <italic>et al</italic>. <xref ref-type="bibr" rid="bib66">2017</xref>). During adulthood the levels decrease considerably but remain relatively stable; decreasing again in old age (Odamaki <italic>et al</italic>. <xref ref-type="bibr" rid="bib115">2016</xref>). Colonisation by bifidobacteria is believed to play pivotal roles in maintaining human health. It is associated with a range of beneficial health effects, involved in the maturation of the immune, digestive and metabolic systems and consequently protecting against the susceptibility to various diseases later in life (Turroni <italic>et al</italic>. <xref ref-type="bibr" rid="bib179">2008</xref>).</p>
<p>Initial bifidobacterial colonisation occurs from birth and is influenced by several extrinsic factors (Arboleya <italic>et al</italic>. <xref ref-type="bibr" rid="bib6">2016</xref>). It has become evident that bifidobacterial species are vertically transmitted from the mother and colonise the intestine of the infant at the very early stages of life (Makino <xref ref-type="bibr" rid="bib92">2018</xref>). Several studies have linked the transmission of bifidobacteria from the mother's vaginal tract, gastrointestinal tract, breast milk, placenta and amniotic fluid to the infant (Makino <italic>et al</italic>. <xref ref-type="bibr" rid="bib93">2013</xref>; Milani <italic>et al</italic>. <xref ref-type="bibr" rid="bib101">2015b</xref>; Collado <italic>et al</italic>. <xref ref-type="bibr" rid="bib27">2016</xref>; Ferretti <italic>et al</italic>. <xref ref-type="bibr" rid="bib42">2018</xref>; de Goffau <italic>et al</italic>. <xref ref-type="bibr" rid="bib53">2019</xref>).</p>
<p>The delivery mode, in particular, has been demonstrated to potently impact this initial colonisation, with vaginally born infants displaying an increased abundance of bifidobacteria compared to those born by caesarean section (Rutayisire <italic>et al</italic>. <xref ref-type="bibr" rid="bib141">2016</xref>; Reyman <italic>et al</italic>. <xref ref-type="bibr" rid="bib131">2019</xref>). More specifically, a study based on analysis of the gut microbiota of mothers and corresponding children demonstrated that vaginally delivered infants share at least one monophyletic strain belonging to the genus <italic>Bifidobacterium</italic> with their mothers, whereas the monophyletic strains were not observed among infants delivered by caesarean section, which is thus indicative of vertical transmission (Makino <italic>et al</italic>. <xref ref-type="bibr" rid="bib93">2013</xref>). Moreover, in recent comparative genome analysis, the strains of bifidobacteria isolated from vaginal and gut microbiomes were indistinguishable, thus enforcing the importance of the maternal vaginal microbiome as a source of bifidobacterial colonisation (Freitas and Hill <xref ref-type="bibr" rid="bib45">2018</xref>).</p>
<p>The maternal birth canal has therefore been implicated as an essential source of bacteria, including bifidobacteria, during the delivery process. Although the colonisation of the gut environment was traditionally thought to begin at birth; new evidence of the presence of bacteria in the uterine environment suggests a primary foetal colonisation (de Goffau <italic>et al</italic>. <xref ref-type="bibr" rid="bib53">2019</xref>). Recent studies also suggest that many foetuses are exposed to microbes through the amniotic fluid that was continuously swallowed from mid to late gestation <italic>in utero</italic> (Chu <italic>et al</italic>. <xref ref-type="bibr" rid="bib24">2017</xref>). However, the ‘in utero colonisation hypothesis’ remains subject to debate. It is argued that, due to methodological difficulties, current scientific evidence does not support the existence of microbiome within the healthy foetal milieu (Perez-Muñoz <italic>et al</italic>. <xref ref-type="bibr" rid="bib118">2017</xref>). A recent study also demonstrates that there was no evidence for the presence of bacteria in the human placenta (de Goffau <italic>et al</italic>. <xref ref-type="bibr" rid="bib53">2019</xref>). Therefore, conclusions remain unachievable, and more studies are needed in this area.</p>
<p>Also, during vaginal delivery, as the infants pass through the birth canal, their oral and nasal cavities are infiltrated with vaginal secretions (Torres-Alipi <italic>et al</italic>. <xref ref-type="bibr" rid="bib173">1990</xref>; Li <italic>et al</italic>. <xref ref-type="bibr" rid="bib85">2018</xref>). For this reason, the neonatal oral fluid at delivery appears to be a mother-to-child-transmission route for bifidobacteria. It is indeed true that bifidobacteria are present in the neonatal oral fluid at birth and the same strains are detected in both the oral fluid and faecal samples collected at one month after birth, suggesting neonatal oral fluid at delivery is an essential source of bacteria from both maternal and environmental ecosystems and may contribute to the early delivery of bacteria to the digestive tracts of neonates (Toda <italic>et al</italic>. <xref ref-type="bibr" rid="bib172">2019</xref>).</p>
<p>Furthermore, accumulating evidence suggests that human breast milk harbours a microbial community and represents a source of commensal bacteria for the neonates (Gueimonde <italic>et al</italic>. <xref ref-type="bibr" rid="bib56">2007</xref>; Jost <italic>et al</italic>. <xref ref-type="bibr" rid="bib63">2014</xref>; Ruiz, García-Carral and Rodriguez <xref ref-type="bibr" rid="bib138">2019</xref>). It has been reported that bifidobacterial strains were present in maternal milk, suggesting the possibility of breast milk as a transmission route of bifidobacteria from the mother to the infant gut (Jost <italic>et al</italic>. <xref ref-type="bibr" rid="bib63">2014</xref>; Makino <italic>et al</italic>. <xref ref-type="bibr" rid="bib94">2015</xref>; Kordy <italic>et al</italic>. <xref ref-type="bibr" rid="bib74">2020</xref>). In this context, feeding mode is considered to be some of the major forces that could impact the colonisation level and species composition of bifidobacteria in the infant gut. Breastfeeding is known to provide the infant with a broad spectrum of biologically active factors including, among others, human milk oligosaccharides (HMOs), that aid in the colonisation of bifidobacteria, as well as a set of commensal microbes to initially colonise the infant gut (Le Doare <italic>et al</italic>. <xref ref-type="bibr" rid="bib31">2018</xref>). Numerous studies comparing the infant gut microbiome of exclusively breast-fed versus formula-fed infants have reported that the guts of breast-fed infants are enriched with <italic>Bifidobacterium</italic> spp. whereas formula-fed infants have a lower abundance of beneficial bacteria (Wang <italic>et al</italic>. <xref ref-type="bibr" rid="bib186">2015</xref>; Lewis and Mills <xref ref-type="bibr" rid="bib84">2017</xref>).</p>
<p>Altogether, these studies provide clues of where and how bifidobacteria colonise the human gut. It is implicated that early life colonisation patterns and successions of bifidobacteria may contribute to the risk of developing health complications during neonatal stage or later in life, highlighting the importance of maintaining proper levels of bifidobacteria in the human gut (Arboleya <italic>et al</italic>. <xref ref-type="bibr" rid="bib6">2016</xref>).</p>
</sec>
<sec id="sec3">
<title>GENERAL FEATURES OF <italic>BIFIDOBACTERIUM</italic> SPECIES</title>
<p>Bifidobacteria are Gram-positive, anaerobic, non-motile, non-spore-forming, polymorphic rods that belong to the family <italic>Bifidobacteriaceae</italic>, order <italic>Bifidobacteriales</italic> and phylum Actinobacteria. Bifidobacteria display a range of distinct cell forms, including curved, short and bifurcated Y shapes. The genomic DNA of bifidobacteria contains a high guanine-plus-cytosine content, with numerous genes involved in the metabolism of dietary and host-derived carbohydrates (Milani <italic>et al</italic>. <xref ref-type="bibr" rid="bib99">2014</xref>; Ventura <italic>et al</italic>. <xref ref-type="bibr" rid="bib183">2014</xref>). At present, the genus <italic>Bifidobacterium</italic> encompasses approximately 80 species, including four species (<italic>Bifidobacterium animalis</italic>, <italic>B. longum</italic>, <italic>B. pseudolongum</italic> and <italic>B. thermacidophilum</italic>) that are further divided into subspecies (Parte <xref ref-type="bibr" rid="bib117">2018</xref>; Sakanaka <italic>et al</italic>. <xref ref-type="bibr" rid="bib145">2020</xref>).</p>
<p>In addition to the presence in the human gut, bifidobacterial species also naturally occur in the gastrointestinal tract of animals as well as a few that are present in sewage, human vagina, oral cavity, breast milk, and foods (Ventura <italic>et al</italic>. <xref ref-type="bibr" rid="bib182">2007</xref>). Bifidobacteria are widely distributed in the gut of social animals (e.g. mammals, birds and insects), whose offspring are dependent on parental care (Turroni, Van Sinderen and Ventura <xref ref-type="bibr" rid="bib180">2011</xref>). Vertical transmission from mother to offspring appears to be a common ecological trademark of this bacterial genus, reflecting a clear evolutionary link between the parent, offspring/progeny and the bifidobacterial species present. A study has revealed that the clades of <italic>Bifidobacteriaceae</italic> arose via cospeciation with humans, chimpanzees, bonobos and gorillas over the past 15 million years, among which the species have been maintained exclusively within host lineages across hundreds of host generations (Moeller <italic>et al</italic>. <xref ref-type="bibr" rid="bib105">2016</xref>). After that, bifidobacteria have developed a diverse number of genetic strategies to adapt to their respective hosts and display differences in their ecological adaptation among species.</p>
<p>In general, bifidobacteria could be categorised into two major groups based on their residential origins; bifidobacterial species that are naturally encountered in the human gastrointestinal tract are referred to as Human-Residential Bifidobacteria (HRB), whereas other species which are the natural inhabitants of animals or environment as non-HRB (Sugahara, Odamaki and Xiao <xref ref-type="bibr" rid="bib163">2015</xref>; Wong <italic>et al</italic>. <xref ref-type="bibr" rid="bib190">2018</xref>) (Fig. <xref ref-type="fig" rid="fig1">1</xref>). Among HRB, <italic>B. breve, B. longum</italic> subsp. <italic>infantis, B. longum</italic> subsp. <italic>longum</italic> and <italic>B. bifidum</italic>, which are the dominant species in the infant's intestines, are referred to as infant-type HRB (Turroni <italic>et al</italic>. <xref ref-type="bibr" rid="bib178">2012</xref>), whereas <italic>B. adolescentis</italic>, <italic>B. catenulatum</italic>, <italic>B. pseudocatenulatum</italic>, <italic>B. longum</italic> subsp. <italic>longum</italic>, etc., which are the dominant species in the adult intestines, are referred to as adult-type HRB (Ishikawa <italic>et al</italic>. <xref ref-type="bibr" rid="bib58">2013</xref>). However, there does not seem to be an absolute infant versus adult division of bifidobacterial (sub)species (Turroni <italic>et al</italic>. <xref ref-type="bibr" rid="bib178">2012</xref>, <xref ref-type="bibr" rid="bib176">2019</xref>). It is noted that HRB strains might not be adapted to particular habitats (gut/blood/human milk) and life stages (infant/adult) within humans, for which the phylogenetic and genomic traits are undisguisable from the strains studied (Freitas and Hill <xref ref-type="bibr" rid="bib45">2018</xref>; Rodriguez and Martiny <xref ref-type="bibr" rid="bib134">2020</xref>). After that, <italic>B. longum</italic> subsp. <italic>longum</italic> was referred to as species that predominantly inhabit both the infant and adult intestines (Odamaki <italic>et al</italic>. <xref ref-type="bibr" rid="bib112">2018</xref>). The ubiquitous distribution of <italic>B. longum</italic> subsp. <italic>longum</italic> species across the human lifespan was suggested to be associated with their genetic diversity which could enhance their adaptation and increase competitiveness in the gut environment, and at least partly due to extensive transmission across family members, a phenomenon that was shown not to be confined to mother-infant pairs (Odamaki et al. <xref ref-type="bibr" rid="bib112">2018</xref>, <xref ref-type="bibr" rid="bib113">2019</xref>).</p>
<fig id="fig1" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p>Distinctive differences in ecological distribution of bifidobacteria. Bifidobacterial species are distributed in a wide range of niches, encompassing the human intestine, the gastrointestinal tract of animals, human vagina, human oral cavity, breast milk, sewage and food. The species that naturally occur in the human host are referred to as Human-Residential Bifidobacteria (HRB). Among HRB, <italic>Bifidobacterium longum</italic> subsp. <italic>infantis</italic>, <italic>B. longum</italic> subsp. <italic>longum</italic>, <italic>B. bifidum</italic> and <italic>B. breve</italic> are recognised as the four exclusive members of the infant gut and are referred to as infant-type HRB. Meanwhile, bifidobacterial species that are predominantly present in the adult gut are referred to as adult-type HRB. Conversely, other species which are the natural inhabitants of animals or environment are referred to as non-HRB. The species of HRB and non-HRB display differences in their ecological adaptation.</p>
</caption>
<graphic xlink:href="fuaa010fig1"></graphic>
</fig>
<p>Meanwhile, non-HRB species encompass <italic>B. animalis</italic> subsp. <italic>animalis</italic>, <italic>B. animalis</italic> subsp. <italic>lactis</italic>, <italic>B. thermophilum</italic>, <italic>B. pseudolongum</italic>, etc., among which some species show a strict ecological adaptation to a particular animal gut (Lamendella <italic>et al</italic>. <xref ref-type="bibr" rid="bib77">2008</xref>). For instance, the non-HRB species <italic>B. magnum</italic> and <italic>B. cuniculi</italic> were ubiquitously found in rabbit faeces, <italic>B. pullorum</italic> and <italic>B. gallinarum</italic> in the chicken intestine, and <italic>B. longum</italic> subsp. <italic>suis</italic> in the piglet faeces (Biavati <italic>et al</italic>. <xref ref-type="bibr" rid="bib13">2000</xref>). Such variations were suggested to be related to the diet, age, and species of the host animals (Mitsuoka and Kaneuchi <xref ref-type="bibr" rid="bib104">1977</xref>). Bifidobacteria are also found in other atypical ecological niches that are either partly linked with the gut: sewage (e.g. <italic>B. minimum</italic> and <italic>B. thermacidophilum</italic>) (Biavati, Scardovi and Moore <xref ref-type="bibr" rid="bib12">1982</xref>; Dong <italic>et al</italic>. <xref ref-type="bibr" rid="bib33">2000</xref>) or completely different from that of the gut: food products (e.g. <italic>B. mongoliense</italic> from fermented mare's milk product and <italic>B. aquikefiri</italic> and <italic>B. tibiigranuli</italic> from water kefir) (Watanabe <italic>et al</italic>. <xref ref-type="bibr" rid="bib188">2009</xref>; Laureys <italic>et al</italic>. <xref ref-type="bibr" rid="bib80">2016</xref>; Eckel <italic>et al</italic>. <xref ref-type="bibr" rid="bib36">2019</xref>). Notably, a small population of <italic>B. animalis</italic> subsp. <italic>lactis</italic>, which is originated from animal gut and commonly incorporated as probiotics in dairy products, was also detected in human faeces (Turroni <italic>et al</italic>. <xref ref-type="bibr" rid="bib177">2009</xref>). It has been suggested that most of the strains of <italic>B. animalis</italic> subsp. <italic>lactis</italic> currently applied in commercial products were genetically indistinguishable (Xiao <italic>et al</italic>. <xref ref-type="bibr" rid="bib193">2010b</xref>; Milani <italic>et al</italic>. <xref ref-type="bibr" rid="bib98">2013</xref>). Its detection might attribute to human diets, such as intake of yoghurt, suggesting that <italic>B. animalis</italic> subsp. <italic>lactis</italic> is not a commensal of human gut microbiota (Kato <italic>et al</italic>. <xref ref-type="bibr" rid="bib66">2017</xref>). Altogether, the identification of bifidobacteria in these environments could be plausibly a consequence of ‘natural’ contaminations from human/animal gut origins and/or from accidental contaminations during the sampling procedures. Conversely, there could be a strong rationale behind the species of HRB being the natural inhabitant of the human gut. As will be discussed later, accumulating evidence suggests that the residential origins of bifidobacteria are associated with a number of significant differences in their physiological features and health-promoting functions in the human host (Xiao <italic>et al</italic>. <xref ref-type="bibr" rid="bib192">2010a</xref>; Odamaki <italic>et al</italic>. <xref ref-type="bibr" rid="bib114">2015</xref>; Sugahara <italic>et al</italic>. <xref ref-type="bibr" rid="bib162">2015</xref>; Sugahara, Odamaki and Xiao <xref ref-type="bibr" rid="bib163">2015</xref>; Minami <italic>et al</italic>. <xref ref-type="bibr" rid="bib103">2016</xref>; Sakurai <italic>et al</italic>. <xref ref-type="bibr" rid="bib147">2017</xref>, <xref ref-type="bibr" rid="bib149">2018</xref>; Wong <italic>et al</italic>. <xref ref-type="bibr" rid="bib190">2018</xref>, <xref ref-type="bibr" rid="bib191">2020</xref>; Sakurai, Odamaki and Xiao <xref ref-type="bibr" rid="bib148">2019</xref>).</p>
</sec>
<sec id="sec4">
<title>NATURAL SELECTION OF INFANT-TYPE HRB BY HUMAN MILK</title>
<p>Human milk is regarded as the principal source of nutrition for infants. It contains a rich source of essential nutrients that nourishes the neonate, supporting proper growth and development. In addition, human milk also provides the neonate with its own microbiota as well as a wide array of bioactive molecules that indirectly can contribute to the establishment of infant gut microbiome (Le Doare <italic>et al</italic>. <xref ref-type="bibr" rid="bib31">2018</xref>). Breast-fed infants are characterised by a gut population dominated by the species of HRB, including <italic>B. bifidum</italic>, <italic>B. breve</italic>, <italic>B. longum</italic> subsp. <italic>longum</italic>, and <italic>B. longum</italic> subsp. <italic>infantis</italic> (Turroni <italic>et al</italic>. <xref ref-type="bibr" rid="bib178">2012</xref>; Makino <italic>et al</italic>. <xref ref-type="bibr" rid="bib94">2015</xref>). This predominance has been explained in part by the high amounts of a class of molecules called human milk oligosaccharides (HMOs) (Lawson <italic>et al</italic>. <xref ref-type="bibr" rid="bib82">2019</xref>). Intriguingly, these molecules are indigestible by the infant, and thus provide no direct nutritive value. Instead, HMOs are thought to selectively support the colonisation of HRB species capable of utilising these diverse substrates (Sela and Mills <xref ref-type="bibr" rid="bib154">2010</xref>; Asakuma <italic>et al</italic>. <xref ref-type="bibr" rid="bib7">2011</xref>; Katayama <xref ref-type="bibr" rid="bib65">2016</xref>). In addition to HMOs, human milk contains antibacterial compounds such as immunoglobulins, lactoferrin, lactoferricin, lysozyme, lactoperoxidase, free fatty acids, antimicrobial peptides and others (Field <xref ref-type="bibr" rid="bib44">2005</xref>). Among them, lysozyme has been reported to be another possible selective factor in human milk that could affect the colonisation of bifidobacterial species in the infant gut (Gagnon <italic>et al</italic>. <xref ref-type="bibr" rid="bib48">2004</xref>; Rada <italic>et al</italic>. <xref ref-type="bibr" rid="bib129">2010</xref>; Minami <italic>et al</italic>. <xref ref-type="bibr" rid="bib103">2016</xref>) (Fig <xref ref-type="fig" rid="fig2">2</xref>).</p>
<fig id="fig2" orientation="portrait" position="float">
<label>Figure 2.</label>
<caption>
<p>Differences in the compatibility with human milk among bifidobacterial species. Infant-type HRB species are adapted to utilise human milk oligosaccharides (HMOs), which are one of the most important component in the human milk that function to selectively support the colonisation of bifidobacteria in infant gut. Infant-type HRB are also highly tolerant to the antibacterial component present in the human milk called lysozyme. In contrary, non-HRB species are excluded by these selective factors present in the human milk. The species of non-HRB are lacking with the enzymatic arsenal dedicated for HMOs utilisation and are sensitive to human milk lysozyme.</p>
</caption>
<graphic xlink:href="fuaa010fig2"></graphic>
</fig>
<sec id="sec4-1">
<title>HMO utilisation</title>
<p>HMOs are the third most abundant substantial component in human milk after lactose and lipids, reaching concentrations of up to 15 g/L in mature human milk (Kobata <xref ref-type="bibr" rid="bib72">2010</xref>). HMOs are complex carbohydrates composing of five monosaccharides: glucose (Glc), galactose (Gal), <italic>N</italic>-acetylglucosamine (GlcNAc), fucose (Fuc) and <italic>N</italic>-acetylneuraminic acid (NeuAc) or sialic acid (Kirmiz <italic>et al</italic>. <xref ref-type="bibr" rid="bib68">2018</xref>). HMOs are synthesised from a lactose (Galβ1–4Glc) backbone at the reducing end and are elongated by the repeats of <italic>β</italic>-1,3- or <italic>β</italic>-1,6-linked lacto-N-biose I (LNB) or <italic>N</italic>-acetyllactosamine (Chen <xref ref-type="bibr" rid="bib21">2015</xref>). The terminal lactose molecules can be further decorated with the addition of fucose and/or sialic acid residues (Bode and Jantscher-Krenn <xref ref-type="bibr" rid="bib14">2012</xref>). With varying degrees of polymerisation and multiple linkage isomers, more than 200 different structures of HMOs have been observed (Thomson, Medina and Garrido <xref ref-type="bibr" rid="bib171">2018</xref>). The overabundant examples of HMOs are lacto-<italic>N</italic>-tetraose (LNT), lacto-<italic>N</italic>-fucopentaose I (LNFP I), lacto-<italic>N</italic>-difucohexaose I (LNDFH I) and 2’-fucosyllactose (2’-FL), with three of the four HMOs are type I chains that exhibit the core structure of LNT (Kunz <italic>et al</italic>. <xref ref-type="bibr" rid="bib76">2000</xref>; Chen <xref ref-type="bibr" rid="bib21">2015</xref>). Degradation of LNT and its constituent component, LNB, has therefore been implicated as an essential step in HMO metabolism.</p>
<sec id="sec4-1-1">
<title>Utilisation of HMOs by bifidobacteria</title>
<p>Bifidobacterial species display differential ability to consume various HMOs, among which the infant-type HRB, namely, <italic>B. bifidum</italic>, <italic>B. breve</italic>, <italic>B. longum</italic> subsp. <italic>infantis</italic> and <italic>B. longum</italic> subsp. <italic>longum</italic> are adapted to utilise HMOs, while the ability was not present in many species of adult-type HRB and the non-HRB (LoCascio <italic>et al</italic>. <xref ref-type="bibr" rid="bib89">2007</xref>; Xiao <italic>et al</italic>. <xref ref-type="bibr" rid="bib192">2010a</xref>; Asakuma <italic>et al</italic>. <xref ref-type="bibr" rid="bib7">2011</xref>). More specifically, considerable differences in HMO utilisation among the four species of infant-type HRB were observed. <italic>B. longum</italic> subsp. <italic>infantis</italic> aggressively consumes LNB and almost all types of HMOs including fucosylated and sialylated molecules, and the consumption capability is highly and widely conserved in this subspecies (Xiao <italic>et al</italic>. <xref ref-type="bibr" rid="bib192">2010a</xref>; Asakuma <italic>et al</italic>. <xref ref-type="bibr" rid="bib7">2011</xref>; Garrido <italic>et al</italic>. <xref ref-type="bibr" rid="bib52">2015</xref>; Thomson, Medina and Garrido <xref ref-type="bibr" rid="bib171">2018</xref>). Meanwhile, the capability to consume HMOs is somewhat variable in <italic>B. bifidum</italic> strains, utilising almost all classes of HMOs and LNB (Xiao <italic>et al</italic>. <xref ref-type="bibr" rid="bib192">2010a</xref>; Asakuma <italic>et al</italic>. <xref ref-type="bibr" rid="bib7">2011</xref>; Garrido <italic>et al</italic>. <xref ref-type="bibr" rid="bib52">2015</xref>; Gotoh <italic>et al</italic>. <xref ref-type="bibr" rid="bib55">2018</xref>; Thomson, Medina and Garrido <xref ref-type="bibr" rid="bib171">2018</xref>). By contrast, the ability of the <italic>B. breve</italic> and <italic>B. longum</italic> subsp. <italic>longum</italic> strains to assimilate HMOs is limited. Most of the <italic>B. breve</italic> strains can utilise only LNT, lacto-<italic>N</italic>-neotetraose (LNnT), and LNB (Xiao <italic>et al</italic>. <xref ref-type="bibr" rid="bib192">2010a</xref>; Asakuma <italic>et al</italic>. <xref ref-type="bibr" rid="bib7">2011</xref>; Ruiz-Moyano <italic>et al</italic>. <xref ref-type="bibr" rid="bib137">2013</xref>; James <italic>et al</italic>. <xref ref-type="bibr" rid="bib61">2016</xref>; Thomson, Medina and Garrido <xref ref-type="bibr" rid="bib171">2018</xref>), whereas the majority of the <italic>B. longum</italic> subsp. <italic>longum</italic> strains can consume solely LNT and LNB, leaving other HMOs unmodified (Xiao <italic>et al</italic>. <xref ref-type="bibr" rid="bib192">2010a</xref>; Asakuma <italic>et al</italic>. <xref ref-type="bibr" rid="bib7">2011</xref>; Garrido <italic>et al</italic>. <xref ref-type="bibr" rid="bib51">2016</xref>; Thomson, Medina and Garrido <xref ref-type="bibr" rid="bib171">2018</xref>). Moreover, a few strains of these two (sub)species have been described to be capable of assimilating exceptionally other complex fucosylated HMOs, such as 2’-FL, 3-fucosyllactose (3-FL), lactodifucotetraose (LDFT) and LNFP I/II/III (Ruiz-Moyano <italic>et al</italic>. <xref ref-type="bibr" rid="bib137">2013</xref>; Garrido <italic>et al</italic>. <xref ref-type="bibr" rid="bib51">2016</xref>; Matsuki <italic>et al</italic>. <xref ref-type="bibr" rid="bib96">2016</xref>).</p>
<p>In addition, HMO utilisation capability by other strains of HRB (<italic>B. kashiwanohense</italic> and <italic>B. pseudocatenulatum</italic>) has been reported (Xiao <italic>et al</italic>. <xref ref-type="bibr" rid="bib192">2010a</xref>; Bunesova, Lacroix and Schwab <xref ref-type="bibr" rid="bib19">2016</xref>). <italic>B. kashiwanohense</italic> was found to consume preferably 2’-FL and 3-FL rather than LNT and LNnT (Bunesova, Lacroix and Schwab <xref ref-type="bibr" rid="bib19">2016</xref>; James <italic>et al</italic>. <xref ref-type="bibr" rid="bib60">2019</xref>). <italic>B. pseudocatenulatum</italic> was shown to be capable of utilising LNT (Matsuki <italic>et al</italic>. <xref ref-type="bibr" rid="bib96">2016</xref>). The ability to consume 2’-FL, 3-FL, LDFT and LNB has also been described in some strains of <italic>B. pseudocatenulatum</italic> (Xiao <italic>et al</italic>. <xref ref-type="bibr" rid="bib192">2010a</xref>; Matsuki <italic>et al</italic>. <xref ref-type="bibr" rid="bib96">2016</xref>). Nonetheless, the majority of adult-type HRB and non-HRB are unable to utilise HMOs. It is not surprising that such capability is absent and/or has been lost in some adult-type HRB and non-HRB that typically reside in the adult and animal intestines as well as other ecological niches.</p>
</sec>
<sec id="sec4-1-2">
<title>Strategies in utilisation of HMOs by infant-type HRB</title>
<p>Infant-type HRB species have evolved two different strategies to degrade HMOs (LoCascio <italic>et al</italic>. <xref ref-type="bibr" rid="bib90">2009</xref>; Garrido, Barile and Mills <xref ref-type="bibr" rid="bib49">2012</xref>; Katayama <xref ref-type="bibr" rid="bib65">2016</xref>). The first strategy is oligosaccharide transporter-dependent, as observed in <italic>B. longum</italic> subsp. <italic>infantis</italic>, <italic>B. breve</italic> and most strains of <italic>B. longum</italic> subsp. <italic>longum</italic>, where a wider array of ATP-binding cassette (ABC) transporters (solute-binding proteins [SBPs]) are required for consumption of a broader set of HMOs; while the second is extracellular glycosidase-dependent, as observed in <italic>B. bifidum</italic> and certain strains of <italic>B. longum</italic> subsp. <italic>longum</italic> that contain the gene encoding lacto-<italic>N</italic>-biosidase (LnbX), where fewer transporters but cell wall-associated glycosyl hydrolases (GHs) are required for HMO utilisation. In the former case, intact HMOs are directly imported into the cells by ABC transporters where they are then hydrolysed intracellularly for consumption. In the latter case, HMOs are hydrolysed outside the cells by cell wall-associated GHs to liberate mono- and/or disaccharides. These liberated carbohydrates are subsequently catabolised inside the cells after their internalisation. This extracellular glycosidase-dependent strategy could then lead to cross-feeding of HMO degradants within <italic>Bifidobacterium</italic> community whereby the extracellularly liberated mono- and disaccharides may be consumed by other bifidobacterial species that are not able to consume the more complex HMOs (Gotoh <italic>et al</italic>. <xref ref-type="bibr" rid="bib55">2018</xref>). This has been observed in the case of sialyllactose-mediated cross-feeding between <italic>B. bifidum</italic> and <italic>B. breve</italic> (Egan <italic>et al</italic>. <xref ref-type="bibr" rid="bib39">2014b</xref>; Nishiyama <italic>et al</italic>. <xref ref-type="bibr" rid="bib107">2018</xref>). In these cases, <italic>B. breve</italic>, which is a non-sialyllactose consumer, can grow on the residual sialic acid that is liberated from sialyllactose by the extracellular sialidase of <italic>B. bifidum</italic>. Noteworthy, given that the abundance of extracellular glycosidase-dependent <italic>B. bifidum</italic> and LnbX-positive <italic>B. longum</italic> subsp. <italic>longum</italic> is generally lower in the infant gut microbiota (Matsuki <italic>et al</italic>. <xref ref-type="bibr" rid="bib96">2016</xref>; Yamada <italic>et al</italic>. <xref ref-type="bibr" rid="bib194">2017</xref>), it is suggested that most of the infant-type HRB employ a transporter-dependent strategy for HMO assimilation.</p>
<p>Comparative genomic analysis has exemplified the functional capabilities of infant-type HRB to assimilate HMOs. Infant-type HRB, including <italic>B. breve</italic>, <italic>B. bifidum</italic>, <italic>B. longum</italic> subsp. <italic>longum</italic>, and <italic>B. longum</italic> subsp. <italic>infantis</italic>, are equipped with sets of HMO-related genes, and such genetic elements are hardly detected in the genomes of the majority species of adult-type HRB and the non-HRB (Garrido <italic>et al</italic>. <xref ref-type="bibr" rid="bib52">2015</xref>; Odamaki <italic>et al</italic>. <xref ref-type="bibr" rid="bib114">2015</xref>; James <italic>et al</italic>. <xref ref-type="bibr" rid="bib61">2016</xref>, <xref ref-type="bibr" rid="bib60">2019</xref>; Sakanaka <italic>et al</italic>. <xref ref-type="bibr" rid="bib145">2020</xref>). The conservation and prevalence of the HMO utilisation genes were remarkably variable among infant-type HRB species. Infant-type HRB species employ different HMO metabolic pathways with different degrees of degradation and size limitations. It appears that HMO-related genes are highly conserved in the genome of <italic>B. longum</italic> subsp. <italic>infantis</italic> for which it contains an army of intracellular GHs and ABC transporters that are necessary for HMO utilisation (Sela <italic>et al</italic>. <xref ref-type="bibr" rid="bib152">2008</xref>; LoCascio <italic>et al</italic>. <xref ref-type="bibr" rid="bib88">2010</xref>). Notably, <italic>B. longum</italic> subsp. <italic>infantis</italic> internalises particular, intact small-mass HMOs, relying on the ABC transporters with defined specificity for individual HMO families (Garrido <italic>et al</italic>. <xref ref-type="bibr" rid="bib50">2011</xref>). In contrast, <italic>B. bifidum</italic> relies on a set of diverse cell wall-associated extracellular GHs including lacto-<italic>N</italic>-biosidase (LnbB) and 1,2-α-L-fucosidase that exhibit similar enzymatic affinities for HMOs compared to the intracellular enzymes from <italic>B. longum</italic> subsp. <italic>infantis</italic> (Wada <italic>et al</italic>. <xref ref-type="bibr" rid="bib185">2008</xref>; Ashida <italic>et al</italic>. <xref ref-type="bibr" rid="bib8">2009</xref>; Turroni <italic>et al</italic>. <xref ref-type="bibr" rid="bib175">2010</xref>; Kitaoka <xref ref-type="bibr" rid="bib69">2012</xref>; Sela <italic>et al</italic>. <xref ref-type="bibr" rid="bib153">2012</xref>). All genes required for extracellular HMO degradation are highly conserved across the species of <italic>B. bifidum</italic> (Gotoh <italic>et al</italic>. <xref ref-type="bibr" rid="bib55">2018</xref>; Sakanaka <italic>et al</italic>. <xref ref-type="bibr" rid="bib145">2020</xref>).</p>
<p>On the other hand, the species of <italic>B. breve</italic> shows high conservation of genes encoding for the SBP of ABC transporters (LNnT-BP (NahS) and GNB/LNB-BP (GltA)) and intracellular enzymes (GH 42 LNT <italic>β</italic>-1,3-galactosidase, GH 20 <italic>β</italic>-<italic>N</italic>-acetylglucosaminidase, GH 2 <italic>β</italic>-1,4-galactosidase and GH 112 GNB/LNB phosphorylase) that are necessary for the degradation of LNT, LNnT and LNB (James <italic>et al</italic>. <xref ref-type="bibr" rid="bib61">2016</xref>; Sakanaka <italic>et al</italic>. <xref ref-type="bibr" rid="bib145">2020</xref>). It was found that, although this species commonly possesses an intracellular GH95 α-fucosidase, the prevalence of the fucosyllactose transporters (FL1-BP and FL2-BP) is remarkably low (Sakanaka <italic>et al</italic>. <xref ref-type="bibr" rid="bib146">2019</xref>), and thus exhibit strain-dependent differences in the capability to utilise fucosylated HMO. Indeed, only a few strains of <italic>B. breve</italic> have been shown to contain GH29 α-fucosidase and the ABC transporter system and are capable of assimilating 2’-FL and larger fucosylated HMOs such as LNFP I/II (Ruiz-Moyano <italic>et al</italic>. <xref ref-type="bibr" rid="bib137">2013</xref>; Matsuki <italic>et al</italic>. <xref ref-type="bibr" rid="bib96">2016</xref>). Moreover, it has been described that the strain <italic>B. breve</italic> UCC2003 utilises LNT and LNnT through two different mechanisms, which resemble the degradation pathway of <italic>B. longum</italic> subsp. <italic>infantis</italic> (James <italic>et al</italic>. <xref ref-type="bibr" rid="bib61">2016</xref>). <italic>B. breve</italic> UCC2003 was also shown to possess functional pathways to internalise and utilise L-fucose (James <italic>et al</italic>. <xref ref-type="bibr" rid="bib60">2019</xref>).</p>
<p>The strains of <italic>B. longum</italic> subsp. <italic>longum</italic> who are recognised as LNT/LNB consumers possess the SBP of ABC transporter (GNB/LNB-BP (GltA)) as well as LNT- and LNB-degrading intracellular enzymes including GH42 LNT <italic>β</italic>-1,3-galactosidase, GH20 <italic>β</italic>-<italic>N</italic>-acetylglucosaminidase, GH2 <italic>β</italic>-1,4-galactosidase and GH 112 GNB/LNB phosphorylase (Suzuki <italic>et al</italic>. <xref ref-type="bibr" rid="bib166">2008</xref>; Garrido <italic>et al</italic>. <xref ref-type="bibr" rid="bib51">2016</xref>; Sakanaka <italic>et al</italic>. <xref ref-type="bibr" rid="bib145">2020</xref>). Moreover, certain strains of <italic>B. longum</italic> subsp. <italic>longum</italic> also contain extracellular GH136 lacto-<italic>N</italic>-biosidase (LnbX) enzyme in its genome (Sakurama <italic>et al</italic>. <xref ref-type="bibr" rid="bib150">2013</xref>). Noteworthy, strains containing LnbX mainly degrade LNT to LNB and lactose, and subsequently import LNB with the SBP of ABC transporters (GNB/LNB-BP (GltA)) and use GNB/LNB phosphorylase (LnpA) for intracellular phosphorolysis, whereas LnbX-negative strains hydrolyse LNT inside the cell with the enzymes LNT β-1,3-galactosidase, β-<italic>N</italic>-acetylglucosaminidase, and β-1,4-galactosidase (Sakurama <italic>et al</italic>. <xref ref-type="bibr" rid="bib150">2013</xref>; Odamaki <italic>et al</italic>. <xref ref-type="bibr" rid="bib114">2015</xref>). Recent studies have also found that specific strains of <italic>B. longum</italic> subsp. <italic>longum</italic> are able to utilise 2’-FL and 3-FL as the unique carbon sources (Garrido <italic>et al</italic>. <xref ref-type="bibr" rid="bib51">2016</xref>; Arboleya <italic>et al</italic>. <xref ref-type="bibr" rid="bib5">2018</xref>). These strains were found to possess a novel gene cluster devoted to the utilisation of fucosylated HMOs, including genes encoding an α-fucosidase enzyme, the ABC transporter system that is responsible for import of fucosylated molecules, and components for fucose metabolism (Garrido <italic>et al</italic>. <xref ref-type="bibr" rid="bib51">2016</xref>; Arboleya <italic>et al</italic>. <xref ref-type="bibr" rid="bib5">2018</xref>).</p>
<p>Interestingly, a recent report has highlighted that some strains of HRB could employ a unique adaptation strategy to assimilate fucosylated HMOs (Sakanaka <italic>et al</italic>. <xref ref-type="bibr" rid="bib146">2019</xref>). The study identified two functionally distinct but overlapping fucosyllactose transporters (FL transporter-1 and -2) that are highly conserved in <italic>B. longum</italic> subsp. <italic>infantis</italic>. FL transporter-2 is capable of taking up 2’-FL, 3-FL, LDFT, and LNFP I, whereas FL transporter-1 can import only the former two molecules. The distinct specificities between FL transporter-1 and -2 (the homologous ABC transporters) may be determined by the partially different FL-binding sites of the corresponding SBPs (Sakanaka <italic>et al</italic>. <xref ref-type="bibr" rid="bib146">2019</xref>). The homologs of FL transporter-1 or -2 are also sporadically distributed among the infant-type HRB species (<italic>B. longum</italic> subsp. <italic>longum</italic> and <italic>B. breve</italic>) as well as a few strains of <italic>B. pseudocatenulatum</italic>, <italic>B. kashiwanohense</italic> and <italic>B. longum</italic> subsp. <italic>suis</italic> (James <italic>et al</italic>. <xref ref-type="bibr" rid="bib60">2019</xref>). It appears that the different capabilities of bifidobacteria to assimilate the fucosylated HMOs are mostly attributed to conservation profiles of FL transporter-1 and/or -2 in bifidobacteria, emphasising the pivotal role of these transporters in dictating the preference of HMO uptake (Garrido <italic>et al</italic>. <xref ref-type="bibr" rid="bib51">2016</xref>; Matsuki <italic>et al</italic>. <xref ref-type="bibr" rid="bib96">2016</xref>; Sakanaka <italic>et al</italic>. <xref ref-type="bibr" rid="bib146">2019</xref>). Furthermore, the SBP homolog gene of FL transporter-2 was found to be positively and actively associated with the abundance of <italic>Bifidobacterium</italic> in the gut of breast-fed infants, suggesting the FL transporter-2 may function as a pivotal fitness factor involved in the dominance and adaptation of bifidobacterial species, particularly infant-type HRB, in the infant gut microbiota (Sakanaka <italic>et al</italic>. <xref ref-type="bibr" rid="bib146">2019</xref>). Another recent report also reinforced the importance of fucosylated HMO metabolism for the successful bifidobacterial establishment in the breast-fed infant gut (James <italic>et al</italic>. <xref ref-type="bibr" rid="bib60">2019</xref>). The study revealed that the four gene homologs (FumFDCE) involved in fucose/fucosylated HMO utilisation pathway are distributed in <italic>Bifidobacterium</italic> strains typically found in infants, including <italic>B. breve</italic> and <italic>B. longum</italic> subsp. <italic>infantis</italic> (James <italic>et al</italic>. <xref ref-type="bibr" rid="bib60">2019</xref>). Collectively, these findings provide intriguing insights into the regulatory networks behind HMO utilisation. It is implicated that infant-type HRB has undergone specific genetic adaptation to and strict co-evolution with the infant host. In addition to the implications to host-bacterial coevolution, this wide array of responses to HMOs may impact probiotics design and applications, where the residential origin and strain-level differences in substrate utilisation require additional considerations.</p>
</sec>
</sec>
<sec id="sec4-2">
<title>Tolerance to lysozyme</title>
<p>A recent study has demonstrated that bifidobacterial species of different residential origins exhibit differential growth characteristics in human milk (Minami <italic>et al</italic>. <xref ref-type="bibr" rid="bib103">2016</xref>). The ability to grow in human milk was found to be highly conserved in infant-type HRB strains of <italic>B. longum</italic> subsp. <italic>infantis</italic> and <italic>B. breve</italic>, while the growth characteristics of <italic>B. longum</italic> subsp. <italic>longum</italic> and <italic>B. bifidum</italic> were shown to be strain-dependent; some strains grew and some retained their inoculated cell numbers. In particular, the tested strains of adult-type HRB and non-HRB were unable to grow in human milk and had reduced viable cell numbers after incubation. Given the fact that human milk also contains an essential amount of lactose (approximately 7% by weight) (Ballard and Morrow <xref ref-type="bibr" rid="bib10">2013</xref>), a carbohydrate source that can be assimilated by bifidobacteria, it seems likely and has indeed been shown to be true that nutrient deficiency may not be the reason for the repressed growth and that the presence of lysozyme in human milk is related to the inability of the strains of adult-type HRB and non-HRB to grow in human milk (Minami <italic>et al</italic>. <xref ref-type="bibr" rid="bib103">2016</xref>).</p>
<p>Lysozyme is a ubiquitous antibacterial enzyme that is present in large quantities in human milk (up to 400 µg/mL), which is approximately 1000–3000-fold higher concentration than the bovine milk (Prieur <xref ref-type="bibr" rid="bib126">1986</xref>). In addition to human milk, lysozyme is naturally present in almost all tissues and biological fluids, such as tears, saliva, sweat, and mucus (Field <xref ref-type="bibr" rid="bib44">2005</xref>). It is therefore plausible that lysozyme susceptibility might represent a threat for bifidobacteria to survive in the human body. Studies have shown that bifidobacterial species that are the natural inhabitants of human intestines (HRB) are more resistant to lysozyme compared to those that are commonly encountered in the animal intestines (non-HRB) (Rada <italic>et al</italic>. <xref ref-type="bibr" rid="bib129">2010</xref>; Rockova <italic>et al</italic>. <xref ref-type="bibr" rid="bib133">2012</xref>; Minami <italic>et al</italic>. <xref ref-type="bibr" rid="bib103">2016</xref>). More specifically, infant-type HRB strains were tolerant to high concentrations of lysozyme, and lysozyme tolerance was positively correlated with their growth in human milk. In contrast, the tested strains of adult-type HRB displayed intermediate tolerance, while non-HRB were relatively sensitive to lysozyme, which would, in turn, led to their failure to grow in human milk (Minami <italic>et al</italic>. <xref ref-type="bibr" rid="bib103">2016</xref>). One study examining the tolerance mechanisms of HRB strains against lysozyme has revealed that differences of lysozyme susceptibility between HRB and non-HRB are independent of the peptidoglycan-degrading property of lysozyme (Sakurai <italic>et al</italic>. <xref ref-type="bibr" rid="bib147">2017</xref>). Instead, the tolerance to lysozyme among some HRB strains is due to their resistance to the cationic properties of lysozyme that are associated with the cytotoxic activity (Sakurai <italic>et al</italic>. <xref ref-type="bibr" rid="bib147">2017</xref>). This finding provides a fundamental insight into how HRB are protected against lysozyme action, which would, in turn, contribute to their colonisation in the human host. Further research is needed to elucidate the specific mechanisms in HRB against lysozyme hydrolysis. Altogether, these findings suggest that the presence of lysozyme in human milk could act as another crucial selective factor that prevents the colonisation of non-HRB in the guts of breast-fed infants.</p>
</sec>
<sec id="sec4-3">
<title>Bifidobacterial human milk compatibility and colonisation of infants</title>
<p>As aforementioned, bifidobacteria of different residential origins display genotypic and phenotypic variations in their compatibility with human milk. Importantly, not all bifidobacteria are equally adapted to consume HMOs and tolerant to human milk lysozyme, which suggests that certain strains of bifidobacteria (infant-type HRB) are better able to colonise a breast-fed infant. This concept has been addressed in a clinical study investigating the gut microbial composition of premature infants — infants who often have a delayed bifidobacterial colonisation in comparison to term infants (Underwood <italic>et al</italic>. <xref ref-type="bibr" rid="bib181">2013</xref>). Premature infants receiving milk were given the probiotic <italic>B. longum</italic> subsp. <italic>infantis</italic> and <italic>B. animalis</italic> subsp. <italic>lactis</italic>. The results demonstrated that <italic>B. longum</italic> subsp. <italic>infantis</italic>, a member of infant-type HRB, colonised better than <italic>B. animalis</italic> subsp. <italic>lactis</italic>, a non-HRB strain, in premature infants exposed to both formula and human milk feeding. This study suggests a close linkage between HMOs and human milk lysozyme (in this case, as part of whole human milk) and colonisation of the gut, specific to certain strains of (infant-type) HRB but not non-HRB (Underwood <italic>et al</italic>. <xref ref-type="bibr" rid="bib181">2013</xref>; Minami <italic>et al</italic>. <xref ref-type="bibr" rid="bib103">2016</xref>; Lawson <italic>et al</italic>. <xref ref-type="bibr" rid="bib82">2019</xref>).</p>
<p>Furthermore, HRB species (<italic>B. longum</italic> subsp. <italic>longum</italic>, <italic>B. breve</italic> and <italic>B. bifidum</italic>) but not the non-HRB species (<italic>B. animalis</italic>) were more frequently detected in the gut microbiota of breast-fed infants (Tannock <italic>et al</italic>. <xref ref-type="bibr" rid="bib169">2013</xref>). In contrast, non-HRB species were more abundant in formula-fed infants than in breast-fed infants, indicating the presence of HMOs and lysozyme in the human milk, but not the infant formulas, contributed to the different abundancy of bifidobacterial species in infant gut microbiota (Tannock <italic>et al</italic>. <xref ref-type="bibr" rid="bib169">2013</xref>; Minami <italic>et al</italic>. <xref ref-type="bibr" rid="bib103">2016</xref>). Another study evaluating the early gut microbial composition of healthy neonates also revealed that the colonisation of the non-HRB species, <italic>B. animalis</italic> subsp. <italic>lactis</italic>, was dictated by the type of feeding (Martin <italic>et al</italic>. <xref ref-type="bibr" rid="bib95">2016</xref>). Noteworthy, <italic>B. animalis</italic> subsp. <italic>lactis</italic> was more frequently detected in the gut microbiota of formula-fed infants and its colonisation was relatively weak in breast-fed infants, suggesting that <italic>B. animalis</italic> subsp. <italic>lactis</italic> might not be a common member of the infant gut microbiota. In contrast, the species of infant-type HRB such as <italic>B. breve</italic> or <italic>B. longum</italic> subsp. <italic>infantis</italic> were confirmed as early infant gut colonisers and their colonisation was not affected by the mode of delivery and type of feeding (Martin <italic>et al</italic>. <xref ref-type="bibr" rid="bib95">2016</xref>). Taken together, these data clearly demonstrated the superiority of infant-type HRB – bifidobacterial species of high compatibility with human milk – to colonise the infant gut, highlighting that certain infant-type HRB strains are more beneficial and could be a better probiotic candidate for human use, especially in infants. In this regard, there must be a good reason why human milk naturally selected the species of HRB, particularly the infant-type HRB, for the developing infants. It is implicated that HRB are better adapted to the intestinal environment of the human host and could contribute to better human health.</p>
</sec>
</sec>
<sec id="sec5">
<title>PHYSIOLOGICAL FUNCTIONS OF HUMAN-RESIDENTIAL BIFIDOBACTERIA (HRB)</title>
<sec id="sec5-1">
<title>Carbohydrate metabolism</title>
<p>Comparative genomic studies of bifidobacterial species have uncovered specific genetic strategies of the members of bifidobacteria to establish and persevere in the human gastrointestinal tract (Milani <italic>et al</italic>. <xref ref-type="bibr" rid="bib99">2014</xref>, <xref ref-type="bibr" rid="bib100">2015a</xref>; Odamaki <italic>et al</italic>. <xref ref-type="bibr" rid="bib114">2015</xref>). It appears that currently known bifidobacterial taxa have undergone a substantial number of gene acquisition events during the evolutionary process where such acquired genes – a specific genetic repertoire that encodes glycosyl hydrolases (GHs) – are related to carbohydrate metabolism. After that, adaptation to habitats rich in complex carbohydrates, as such in the human gut, is seen as the main driving force responsible for speciation among members of the genus <italic>Bifidobacterium</italic> (Milani <italic>et al</italic>. <xref ref-type="bibr" rid="bib102">2016</xref>).</p>
<p>Even though bifidobacteria are not a dominant member of the adult gut microbiota, their functional biological roles in the metabolism of dietary and host-derived glycans cannot be neglected. Bifidobacteria display saccharolytic behaviour and their ability to colonise and survive in the gastrointestinal tract is largely dependent on their carbohydrate metabolic capabilities (Milani <italic>et al</italic>. <xref ref-type="bibr" rid="bib102">2016</xref>). According to the Carbohydrate Active Enzymes (CAZy) classification, the pan-genome of the <italic>Bifidobacterium</italic> genus is among the largest predicted glycobiomes of the known gut commensals, with a large proportion of annotated genes encode an enzymatic arsenal involved in carbohydrate metabolism, including GHs, glycosyltransferases, and carbohydrate esterases (Milani <italic>et al</italic>. <xref ref-type="bibr" rid="bib100">2015a</xref>). The bifidobacterial glycobiome is enriched in enzymes belonging to the GH13 family, which are the typical enzymes for degradation of a wide range of complex carbohydrates, such as starch, glycogen, and related substrates (e.g. amylose, amylopectin, pullulan, maltodextrin and cyclomaltodextrin), as well as palatinose, stachyose, raffinose and melibiose (Milani <italic>et al</italic>. <xref ref-type="bibr" rid="bib100">2015a</xref>). Notably, all these sugars are dominant glycans found in the adult mammalian diet. Moreover, part of the predicted glycobiome of bifidobacteria is extracellular, allowing them to degrade carbohydrates whose direct uptake is not possible due to the size and complexity of the glycan.</p>
<p>Intriguingly, it appears that the occurrence of HRB in the human gut is supported by their metabolic abilities about various complex, host-indigestible carbohydrates either (in)directly derived from the host (i.e. mucin and HMOs) or the diet (Milani <italic>et al</italic>. <xref ref-type="bibr" rid="bib99">2014</xref>, <xref ref-type="bibr" rid="bib100">2015a</xref>, <xref ref-type="bibr" rid="bib102">2016</xref>). Analyses of the genome sequences of the various type strains representing HRB and non-HRB revealed an abundant presence of genes related to plant-derived carbohydrate metabolism in the genomes of HRB, especially the adult-type HRB, <italic>B. adolescentis</italic> and <italic>B. longum</italic> subsp. <italic>longum</italic>. The genome of <italic>B. adolescentis</italic> is particularly enriched with a much larger set of GH 13 enzymes, which include amylase, pullulanase, and cyclomaltodextrinase, than other HRB species, exemplifying their capabilities to metabolise various dietary starch and starch-like oligo/polysaccharides such as amylopectin, pullulan, maltotriose, and maltodextrin (Duranti <italic>et al</italic>. <xref ref-type="bibr" rid="bib35">2014</xref>, <xref ref-type="bibr" rid="bib34">2016</xref>). Such genetic architecture may reflect an adaptation of <italic>B. adolescentis</italic> species to the adult diet, which often contains high amounts of plant-derived glycans, and thus highlighting the superiority of this HRB species to persist in the gastrointestinal tract of adult human beings. Moreover, the analyses of fermentation profiles of <italic>B. adolescentis</italic> strains have further exemplified their preference for the utilisation of different sugars (e.g. galactose, mannose and glucose), as well as plant-derived carbohydrates that are typically present in the human diet, such as starch (Duranti <italic>et al</italic>. <xref ref-type="bibr" rid="bib35">2014</xref>).</p>
<p>Another important sign of bifidobacterial adaptation to the human gut is the ability of the HRB species, <italic>B. longum</italic> subsp. <italic>longum</italic>, to utilise a wide variety of plant-derived dietary carbohydrates. <italic>B. longum</italic> subsp. <italic>longum</italic> was shown to be genetically well equipped with a substantial number of GHs (e.g. xylanase, arabinosidase, galactosidase, neopullanase isomaltase, inulinase, glucosidase, hexosaminidase, and mannosidase), oligosaccharide transporters and proteins with a cell-surface anchor motif, reflecting the genetic strategies employed by this species to survive and compete in its ecological niche (Schell <italic>et al</italic>. <xref ref-type="bibr" rid="bib151">2002</xref>; Odamaki <italic>et al</italic>. <xref ref-type="bibr" rid="bib114">2015</xref>; Fujita <italic>et al</italic>. <xref ref-type="bibr" rid="bib47">2019</xref>). Noteworthy, a large number of GH 43 and 51 family members, which are enzymes responsible for the breakdown of arabinofuranoside and xylan, were found to be specific to <italic>B. longum</italic> subsp. <italic>longum</italic> as well as <italic>B. adolescentis</italic> and other adult-type HRB (Odamaki <italic>et al</italic>. <xref ref-type="bibr" rid="bib114">2015</xref>; Duranti <italic>et al</italic>. <xref ref-type="bibr" rid="bib34">2016</xref>; Komeno <italic>et al</italic>. <xref ref-type="bibr" rid="bib73">2019</xref>). The presence of such genetic elements for utilisation of plant-derived carbohydrates, which are assumed to be not introduced into infant gut before weaning, provides an advantage for this species to colonise in the human intestine. It appears that <italic>B. longum</italic> subsp. <italic>longum</italic> might play a key role in infant's digestion during weaning where a non-milk diet containing complex carbohydrates are being introduced for the first time. Consequently, such genetic architecture may explain why only <italic>B. longum</italic> subsp. <italic>longum</italic> predominantly inhabit in both the infant and adult intestines (Pacheco <italic>et al</italic>. <xref ref-type="bibr" rid="bib116">2015</xref>; Odamaki <italic>et al</italic>. <xref ref-type="bibr" rid="bib112">2018</xref>).</p>
<p>Moreover, <italic>B. breve</italic> is another HRB species that deserves a special mention as it appears to possess the ability to metabolise a wide range of <italic>α</italic>/<italic>β</italic>-glucose- and <italic>α</italic>/<italic>β</italic>-galactose-containing carbohydrates, corroborating its niche-specific adaptation to both infant and adult guts (Pokusaeva, Fitzgerald and van Sinderen <xref ref-type="bibr" rid="bib120">2011</xref>; Bottacini <italic>et al</italic>. <xref ref-type="bibr" rid="bib16">2018</xref>). Specific strains of <italic>B. breve</italic> encode various carbohydrate-modifying enzymes including α-glucosidases (belonging to the GH13 and GH31 families) that are involved in hydrolysis of <italic>α</italic>-glucosidic linkages usually present in di-, oligo- and polysaccharides (e.g. maltose, starch and related α-glycans) (Pokusaeva <italic>et al</italic>. <xref ref-type="bibr" rid="bib122">2009</xref>; Kelly <italic>et al</italic>. <xref ref-type="bibr" rid="bib67">2016</xref>), <italic>β</italic>-glucosidases (belonging to the GH1 and GH3 families) that are involved in assimilation of a variety of glycan substrates such as cellobiose and cellodextrin (Pokusaeva <italic>et al</italic>. <xref ref-type="bibr" rid="bib123">2011</xref>; Bottacini <italic>et al</italic>. <xref ref-type="bibr" rid="bib16">2018</xref>) and <italic>β</italic>-galactosidases (belonging to the GH2 and GH42 families) that are involved in degradation of lactose, galactan and galacto-oligossacharides (O'Connell Motherway, Fitzgerald and van Sinderen <xref ref-type="bibr" rid="bib109">2011</xref>; O'Connell Motherway <italic>et al</italic>. <xref ref-type="bibr" rid="bib110">2013</xref>). It has been found that certain <italic>B. breve</italic> strains were able to utilise starch, pullulan and amylopectin (Ryan, Fitzgerald and van Sinderen <xref ref-type="bibr" rid="bib144">2006</xref>). In addition, the strain <italic>B. breve</italic> UCC2003 is reported to encode various carbohydrate-modifying enzymes including amylopullulanase, endogalactanase, β-fructofuranosidase, β-1,4-glucosidase, α-1,6-glucosidases, and ribokinase) that allow it to metabolise various glycans such as sucrose, fructose, starch, amylopectin, panose, cellobiose, and ribose (Ryan, Fitzgerald and van Sinderen <xref ref-type="bibr" rid="bib143">2005</xref>; Motherway <italic>et al</italic>. <xref ref-type="bibr" rid="bib106">2008</xref>; O'Connell Motherway <italic>et al</italic>. <xref ref-type="bibr" rid="bib111">2009</xref>; Pokusaeva <italic>et al</italic>. <xref ref-type="bibr" rid="bib121">2010</xref>; O'Connell Motherway, Fitzgerald and van Sinderen <xref ref-type="bibr" rid="bib109">2011</xref>; Pokusaeva, Fitzgerald and van Sinderen <xref ref-type="bibr" rid="bib120">2011</xref>; Kelly <italic>et al</italic>. <xref ref-type="bibr" rid="bib67">2016</xref>). Given that <italic>B. breve</italic> is particularly abundant in early life where starch-containing foods, fruits and cereals or vegetables are among the first digestible dietary carbohydrates introduced at weaning (Stephen <italic>et al</italic>. <xref ref-type="bibr" rid="bib160">2012</xref>), the presence of such genetic elements for hydrolysis of glycosidic linkages may aid in their colonisation and persistence in the (infant) gut. Extensive research on carbohydrate utilisation in <italic>B. breve</italic> using a combination of comparative genomics, gene-trait matching (genotype-phenotype association) and functional genomics have also revealed that bifidobacterial mutualism and carbohydrate syntrophy occurs in the infant's gut wherein the species of <italic>B. breve</italic> may, perhaps, co-operatively, cross-feed with other (bifido)bacterial species like <italic>B. bifidum</italic> or <italic>B. longum</italic> subsp. <italic>longum</italic> in order to sustain growth on the various plant-derived carbohydrates (Pokusaeva, Fitzgerald and van Sinderen <xref ref-type="bibr" rid="bib120">2011</xref>; Egan <italic>et al</italic>. <xref ref-type="bibr" rid="bib39">2014b</xref>; Bottacini <italic>et al</italic>. <xref ref-type="bibr" rid="bib16">2018</xref>).</p>
<p>Furthermore, one study examining the metabolic capabilities of probiotic strains of bifidobacteria and lactic acid bacteria has revealed the superiority of HRB strains to assimilate galactooligosaccharide (GOS), a group of prebiotic compounds that are widely used in infant nutrition to stimulate growth of beneficial gut bacteria (Böger <italic>et al</italic>. <xref ref-type="bibr" rid="bib15">2019</xref>). HRB strains tested (<italic>B. adolescentis</italic> DSM 20 083, <italic>B. breve</italic> DSM 20 091, <italic>B. bifidum</italic> DSM 20 456, <italic>B. longum</italic> subsp. <italic>infantis</italic> DSM 20 088) grew well and were more efficient for GOS utilisation than non-HRB strains (<italic>B. lactis</italic> W51 and W52), with a distinct degree of polymerisation and different glycosidic linkage compositions. Noteworthy, most of the branched GOS were only consumed by HRB strains of <italic>B. breve</italic>, <italic>B. adolescentis</italic>, and <italic>B. longum</italic> subsp. <italic>infantis</italic> (Böger <italic>et al</italic>. <xref ref-type="bibr" rid="bib15">2019</xref>). This study suggests that HRB strains particularly <italic>B. breve</italic> and <italic>B. longum</italic> subsp. <italic>infantis</italic> are most suitable for symbiotic mixtures with GOS.</p>
<p>On the other hand, several species of non-HRB (<italic>B. animalis</italic> subsp. <italic>lactis</italic>, <italic>B. pseudolongum</italic> subsp. <italic>pseudolongum</italic>, <italic>B. pseudolongum</italic> subsp. <italic>globusum</italic>, and <italic>B. thermophilum</italic>) were found lacking the sets of genes encoding enzymes involved in the metabolism of arabinoxylan oligosaccharides (Rivière <italic>et al</italic>. <xref ref-type="bibr" rid="bib132">2014</xref>). Notably, the species of <italic>B. animalis</italic> subsp. <italic>lactis –</italic>a common probiotic agent used in dairy products and dietary supplements – can only metabolise a very minimal number of carbohydrates (Milani <italic>et al</italic>. <xref ref-type="bibr" rid="bib98">2013</xref>, <xref ref-type="bibr" rid="bib100">2015a</xref>). It is therefore plausible that the genetic architecture of non-HRB for plant-derived carbohydrates metabolism is associated with their corresponding hosts, revealing a co-evolution host–microbe profile. Nonetheless, such genetic elements may have undergone massive genome decay as a result of its industrial exploitation, which has involved long-term cultivation of <italic>B. animalis</italic> subsp. <italic>lactis</italic> on synthetic media (Milani <italic>et al</italic>. <xref ref-type="bibr" rid="bib98">2013</xref>).</p>
<p>HRB species have also been shown to be capable of utilising mucin as a nutrient source in order to colonise and survive within the host intestinal lining (Kiyohara <italic>et al</italic>. <xref ref-type="bibr" rid="bib70">2012</xref>; Katayama <xref ref-type="bibr" rid="bib65">2016</xref>). Mucins are host-derived glycans, secreted by intestinal goblet cells that essentially coat the surface of the intestinal mucosa. The main monosaccharides components are <italic>N</italic>-acetylglucosamine, <italic>N</italic>-acetylgalactosamine, and galactose, and these glycoproteins are decorated with fucose, sialic acid, and sulphate groups (Tailford <italic>et al</italic>. <xref ref-type="bibr" rid="bib168">2015</xref>). It has been reported that most strains of <italic>B. longum</italic> subsp. <italic>longum</italic> and <italic>B. bifidum</italic> are equipped with the gene homologs encoding endo-α-<italic>N</italic>-acetylgalactosaminidase and are thus capable of hydrolysing the core structures of mucin-type oligosaccharides, Galβ1–3GalNAcα-O-Ser/Thr (or T-antigen) to Galβ1–3GalNAc (Fujita <italic>et al</italic>. <xref ref-type="bibr" rid="bib46">2005</xref>). Also, infant-type HRB strains of <italic>B. longum</italic> subsp. <italic>infantis</italic>, <italic>B. longum</italic> subsp. <italic>longum</italic>, and <italic>B. breve</italic> have also been shown to possess the gene homolog encoding α-<italic>N</italic>-acetylgalactosaminidase (NagBb) that hydrolyses GalNAcα-O-Ser/Thr (Tn antigen) from the core-3-mucin-type <italic>O</italic>-glycans (GlcNAcβ1–3GalNAcα-O-Ser/Thr) (Odamaki <italic>et al</italic>. <xref ref-type="bibr" rid="bib114">2015</xref>). In particular, the strain <italic>B. breve</italic> UCC2003, which is a versatile bacterium from a metabolic perspective, was also shown to contain sulfatase-encoding gene clusters that allow it to metabolise <italic>N</italic>-acetylglucosamine-6-sulfate (GlcNAc-6-S), but apparently not on GlcNAc, as a sole carbon source (Pokusaeva, Fitzgerald and van Sinderen <xref ref-type="bibr" rid="bib120">2011</xref>; Egan <italic>et al</italic>. <xref ref-type="bibr" rid="bib37">2016</xref>). Interestingly, it is reported that <italic>B. breve</italic> UCC2003 produces an intracellular sulfatase enzymes and appears to employs a cross-feeding strategy with other members of the gut microbiota in order to gain access to mucin-derived sulphated monosaccharides (Egan <italic>et al</italic>. <xref ref-type="bibr" rid="bib38">2014a</xref>, <xref ref-type="bibr" rid="bib37">2016</xref>). Nonetheless, non-HRB strains of <italic>B. animalis</italic> were found lacking these genetic elements. These findings reflect the fitness and competitiveness of HRB strains, particularly the infant-type HRB, to survive and persist in the human intestine, where the glycans produced by the host serve as a carbon source for these bifidobacterial species.</p>
<p>Furthermore, these genetic data were substantiated by the analysis of mucin degradation of infant-type HRB, which highlighted the superior capability of the strains of <italic>B. bifidum</italic> D119 and L22, <italic>B. breve</italic> NCIMB8807 and <italic>B. longum</italic> subsp. <italic>longum</italic> NCIMB8809 to utilise mucin as a carbon source and grow well in mucin-containing defined medium (Ruas-Madiedo <italic>et al</italic>. <xref ref-type="bibr" rid="bib136">2008</xref>). In contrast, <italic>B. animalis</italic> and <italic>B. pseudocatenulatum</italic> strains, which are lacking mucin-utilisation-related genes (<italic>afcA</italic> and <italic>engBF</italic> glycosidase genes), were not able to utilise mucin and had minimal growth (Ruas-Madiedo <italic>et al</italic>. <xref ref-type="bibr" rid="bib136">2008</xref>). It is therefore implicated that HRB strains, particularly infant-type, are more competent to assimilate mucin, survive, and persist in the human gastrointestinal tract.</p>
<p>These findings suggest that HRB possess adaptive advantages and competitiveness to colonise in the human gut over the non-HRB that are less specialised with the human gut environment. Although the carbohydrates assimilation capability of bifidobacteria is more likely to be dependent on strain-specificity, the driving force of residential origin cannot be neglected. For instance, the HRB strains that are capable of utilising non-digestible glycans would aid in human digestion of glycans with valuable nutrient values which would otherwise be lost from the body and unused as waste to the outside environment.</p>
</sec>
<sec id="sec5-2">
<title>Production of folate</title>
<p>In addition to carbohydrate metabolisms and adaptation to a wide variety of carbohydrates, bifidobacterial species that are naturally residing in the human gut (HRB) also possess interesting feature concerning folate biosynthetic capabilities. Folate, also known as vitamin B9 or pteroyl-L-glutamate, is water-soluble vitamin that plays a role as a cofactor. It is required for efficient DNA replication, repair and methylation, and synthesis of nucleotides, vitamins and certain amino acids (Jacob <xref ref-type="bibr" rid="bib59">2000</xref>; Lucock <xref ref-type="bibr" rid="bib91">2000</xref>). For this key role in the cell cycle, various fast proliferating cells such as leukocytes, erythrocytes, and enterocytes require high levels of folate for growth (Jacob <xref ref-type="bibr" rid="bib59">2000</xref>).</p>
<p>Humans are auxotroph for folate; they cannot synthesise on their own and must obtain it exogenously through the diet (e.g. leafy green vegetables, yeast extracts, liver, beans) or indigenous folate-synthesising bacteria (Strozzi and Mogna <xref ref-type="bibr" rid="bib161">2008</xref>; Aufreiter <italic>et al</italic>. <xref ref-type="bibr" rid="bib9">2009</xref>). Folate deficiency has been associated with malformation of the neural tube during embryonic development and increased risk of megaloblastic anaemia, certain forms of cancer, and cardiovascular diseases (Rayburn, Stanley and Garrett <xref ref-type="bibr" rid="bib130">1996</xref>; Choi and Mason <xref ref-type="bibr" rid="bib23">2000</xref>; Stanger <xref ref-type="bibr" rid="bib159">2002</xref>). Moreover, this vitamin is particularly important for some population groups, including the elderly, children, and pregnant women.</p>
<p>The folate molecule contains a pterin moiety originating from 6-hydroxymethyl-7,8-dihydropterin pyrophosphate (DHPPP), bound to a unit of <italic>para</italic>-aminobenzoic acid (<italic>p</italic>ABA). The <italic>de novo</italic> biosynthesis process of folate necessitates both DHPPP and <italic>p</italic>ABA, for which the synthesis of these precursors requires the three basic building blocks: guanosine triphosphate (GTP), chorismate, and glutamate. DHPPP is formed from GTP in four consecutive steps, while <italic>p</italic>ABA can be produced from chorismate in the shikimate pathway (Rossi, Amaretti and Raimondi <xref ref-type="bibr" rid="bib135">2011</xref>; Andlid, D'Aimmo and Jastrebova <xref ref-type="bibr" rid="bib3">2018</xref>). Subsequently, the DHPPP and <italic>p</italic>ABA are joined together with the formation of a C-N bond, catalysed by the enzyme dihydropteroate synthase (DHPS, EC 2.5.1.15) to form 7,8-dihydropteroate (DHP). Further, DHP is reduced to the biologically active cofactor tetrahydrofolate (THF) (Rossi, Amaretti and Raimondi <xref ref-type="bibr" rid="bib135">2011</xref>; Andlid, D'Aimmo and Jastrebova <xref ref-type="bibr" rid="bib3">2018</xref>).</p>
<p>Bifidobacteria have been shown to possess the folate synthesising machinery, albeit not all species have the complete enzymatic armoury (Rossi, Amaretti and Raimondi <xref ref-type="bibr" rid="bib135">2011</xref>; LeBlanc <italic>et al</italic>. <xref ref-type="bibr" rid="bib83">2013</xref>). Comparative genomic analysis has provided intriguing insights into the genes and corresponding enzymes presumptively involved in bifidobacterial folate biosynthesis. Based on the available genome information, all sequenced bifidobacterial species have thus far shown to harbour the required genes for the shikimate pathway and thus can produce chorismate (Barrangou <italic>et al</italic>. <xref ref-type="bibr" rid="bib11">2009</xref>; Ventura <italic>et al</italic>. <xref ref-type="bibr" rid="bib184">2009</xref>; Turroni <italic>et al</italic>. <xref ref-type="bibr" rid="bib175">2010</xref>). However, not all species are capable of converting chorismate into <italic>p</italic>ABA. Although all species harbour <italic>pabA</italic> gene encoding ADCS enzyme, only the HRB species of <italic>B. adolescentis</italic> and <italic>B. dentium</italic> possess the <italic>pabC</italic> gene encoding for ADCL enzyme and can, therefore, synthesise <italic>p</italic>ABA <italic>de novo</italic> (Rossi, Amaretti and Raimondi <xref ref-type="bibr" rid="bib135">2011</xref>; Andlid, D'Aimmo and Jastrebova <xref ref-type="bibr" rid="bib3">2018</xref>). The other species would require <italic>p</italic>ABA supplementation in order to accomplish folate production.</p>
<p>Moreover, all sequenced HRB species (<italic>B. adolescentis</italic>, <italic>B. dentium</italic>, and <italic>B. longum</italic> subsp. <italic>longum</italic>) harbour a cluster of <italic>fol</italic> genes for DHPPP biosynthesis and are predicted to carry out the condensation of DHPPP and <italic>p</italic>ABA (Rossi, Amaretti and Raimondi <xref ref-type="bibr" rid="bib135">2011</xref>). The non-HRB species of <italic>B. animalis</italic> subsp. <italic>lactis</italic> were, however, found missing the key genes (<italic>folE</italic> and <italic>folBK</italic>) needed for DHPPP biosynthesis and the <italic>folP</italic> gene encoding DHPS, enzyme involves in the condensation of DHPPP and <italic>p</italic>ABA (Rossi, Amaretti and Raimondi <xref ref-type="bibr" rid="bib135">2011</xref>; LeBlanc <italic>et al</italic>. <xref ref-type="bibr" rid="bib83">2013</xref>; Milani <italic>et al</italic>. <xref ref-type="bibr" rid="bib99">2014</xref>), and are therefore auxotroph for folates even if <italic>p</italic>ABA is present in the environment. Collectively, it is conceivable that the HRB species of <italic>B. adolescentis</italic> and <italic>B. dentium</italic> can produce folate <italic>de novo</italic>, <italic>B. longum</italic> subsp. <italic>longum</italic> requires <italic>p</italic>ABA supplementation, and the non-HRB species of <italic>B. animalis</italic> requires folate supplementation.</p>
<p>Furthermore, many studies have assessed the capabilities of bifidobacterial species to produce folate and their possible contribution to the folate intake of the host (Pompei <italic>et al</italic>. <xref ref-type="bibr" rid="bib124">2007a</xref>; D'Aimmo et al. <xref ref-type="bibr" rid="bib28">2012</xref>, <xref ref-type="bibr" rid="bib29">2014</xref>; Sugahara <italic>et al</italic>. <xref ref-type="bibr" rid="bib162">2015</xref>). It appears that the mere ability to synthesise folate is restricted to certain species/strains of bifidobacteria, and to a large extent, their capabilities are also highly associated with the residential origins, leading to distinct differences between HRB and non-HRB in folate production (Sugahara <italic>et al</italic>. <xref ref-type="bibr" rid="bib162">2015</xref>). For instance, while most HRB strains were capable of producing high levels of folate, non-HRB strains produce the least amount or nothing (autotroph) (Sugahara <italic>et al</italic>. <xref ref-type="bibr" rid="bib162">2015</xref>). Interestingly, the folate production capacity in bifidobacteria is reported to be correlated with the phylogenetic lineage. Several HRB species isolated from non-human primates (<italic>B. adolescentis</italic> and <italic>B. dentium</italic>) were capable of producing a high level of total folate, whereas the non-HRB species isolated from non-primates (<italic>B. animalis</italic> subsp. <italic>animalis</italic>, <italic>B. animalis</italic> subsp. <italic>lactis</italic>, <italic>B. pseudolongum</italic> subsp. <italic>globosum</italic>, <italic>B. asteroides</italic>, <italic>B. coryneforme</italic>, and <italic>B. indicum</italic>) were incapable (D'Aimmo <italic>et al</italic>. <xref ref-type="bibr" rid="bib29">2014</xref>). It has become evident that folate production is characteristic of HRB but not of non-HRB. Adaptations to habitats that frequently contain external folate, mainly the animal intestines, have presumably led to reduced selection pressure for <italic>de novo</italic> folate biosynthesis and are most likely rendering many strains and possibly whole species of non-HRB to have lost their ability to synthesise folate (Andlid, D'Aimmo and Jastrebova <xref ref-type="bibr" rid="bib3">2018</xref>).</p>
<p>Some <italic>in vivo</italic> studies further confirmed the capabilities of HRB to produce high folate levels and to act as an endogenous source of this vitamin by elucidating its release inside the intestines of the murine model and human subject (Pompei <italic>et al</italic>. <xref ref-type="bibr" rid="bib125">2007b</xref>; Strozzi and Mogna <xref ref-type="bibr" rid="bib161">2008</xref>; Sugahara <italic>et al</italic>. <xref ref-type="bibr" rid="bib162">2015</xref>). In an <italic>in vivo</italic> study using germ-free mice administered with a single strain of bifidobacteria, the levels of folate were found to be higher in mice administered with the HRB strain of <italic>B. longum</italic> subsp. <italic>longum</italic> than the non-HRB strain of <italic>B. animalis</italic> subsp. <italic>lactis</italic>. This was accompanied by a significant improvement in the haematological indicators related to anaemia in germ-free mice colonised with HRB strain (Sugahara <italic>et al</italic>. <xref ref-type="bibr" rid="bib162">2015</xref>). The study suggests that folate-producing HRB strain could be more beneficial than those of the non-HRB strain in protecting the human host against folate deficiency health complications such as anaemia. Furthermore, in a human pilot study, daily consumption of the HRB strains (<italic>B. adolescentis</italic> DSMZ 18 352, <italic>B. adolescentis</italic> DSMZ 18 350, and <italic>B. pseudocatenulatum</italic> DSMZ 18 353) for 30 days resulted in a significant higher folate content in the intestinal lumen, indicating these HRB strains are capable of producing folate and providing an endogenous source of this vitamin to the human host (Strozzi and Mogna <xref ref-type="bibr" rid="bib161">2008</xref>).</p>
<p>The species of HRB have thus far been shown to harbour a functioning folate biosynthesis machinery and exhibit a greater capacity for folate production than the non-HRB. It seems possible that HRB species have been favoured during the evolution with the human host wherein they can both colonise the human gut and produce folate (symbiotic coevolution). Whether this is true or not is unknown but the findings show a great promise for high-folate producing HRB strains supplementation in improving human folate status. Folate-producing HRB strains, either incorporated in functional foods or as trophic probiotics, would help in intestinal homeostasis of vitamins and confer beneficial effects on human health.</p>
</sec>
<sec id="sec5-3">
<title>Degradation of food-derived opioid peptides</title>
<p>Food-derived opioid peptides are substances generated from enzymatic hydrolysis of dietary proteins, including milk, vegetable, cereal, and meat/poultry that are having morphine-like activities (Teschemacher <xref ref-type="bibr" rid="bib170">2003</xref>). Due to structural similarity to endogenous opioids, food-derived opioid peptides could be recognised by opioid receptors that are found primarily in the central nervous system and gastrointestinal tract, and display opioid-like molecular and physiological activities (Liu and Udenigwe <xref ref-type="bibr" rid="bib87">2019</xref>). The first identified and widely studied milk casein-derived opioid peptide was β-casomorphin-7 (BCM-7; Tyr-Pro-Phe-Pro-Gly-Pro-Ile) released from β-casein of bovine or human milk during technological processes and/or enzymatic digestion in the intestine (Brantl <italic>et al</italic>. <xref ref-type="bibr" rid="bib17">1981</xref>). Studies have suggested that BCM-7 may pass through human intestinal barriers, and could, in turn, influence on nervous, digestive and immune functions by altering the gene expression of µ-opioid receptors located on cell surfaces of these systems (Liu and Udenigwe <xref ref-type="bibr" rid="bib87">2019</xref>). BCMs -4, -5, and -6, which are derived by sequential removal of three, two or one amino acid residues, respectively from the C-terminus of BCM-7, have also been demonstrated to possess opioid agonist effects (Brantl <italic>et al</italic>. <xref ref-type="bibr" rid="bib17">1981</xref>). Also, gluten exorphin and gliadorphin-7 (or gliadinomorphin-7), derived from the gluten found in wheat flour, rye, barley and oats, were acknowledged as substances with opioid activity (Pruimboom and De Punder <xref ref-type="bibr" rid="bib127">2015</xref>).</p>
<p>Food-derived opioid peptides have received much attention in human health. Some food-derived opioid peptides have been reported to exert beneficial health bioactivities in healthy humans (Rutherfurd-Markwick <xref ref-type="bibr" rid="bib142">2012</xref>; Liu and Udenigwe <xref ref-type="bibr" rid="bib87">2019</xref>), however, some studies implicate that they may have adverse health effects in susceptible people. Milk β-casein-derived BCM-7, for instance, has been demonstrated to be associated with many negative health outcomes, including autism, type I diabetes, sudden infant death syndrome, and atopic dermatitis (Wasilewska <italic>et al</italic>. <xref ref-type="bibr" rid="bib187">2011</xref>; Fiedorowicz <italic>et al</italic>. <xref ref-type="bibr" rid="bib43">2014</xref>; Sokolov <italic>et al</italic>. <xref ref-type="bibr" rid="bib158">2014</xref>; Chia <italic>et al</italic>. <xref ref-type="bibr" rid="bib22">2017</xref>). BCMs have been reported to be a causal trigger to apnoea in sudden infant death syndrome for which penetration of BCMs into the infant's immature central nervous system may inhibit the respiratory centre in the brainstem, thereby leading to abnormal ventilator responses, apnoea, and death (Sun <italic>et al</italic>. <xref ref-type="bibr" rid="bib165">2003</xref>). Several other studies provide direct evidence that BCM-7 is positively correlated with childhood mental disorders and apparent-life threatening events in infants wherein an elevated level of BCM-7 was detected in the urine of autistic children (Sokolov <italic>et al</italic>. <xref ref-type="bibr" rid="bib158">2014</xref>) and the sera of infants with apnoea (Wasilewska <italic>et al</italic>. <xref ref-type="bibr" rid="bib187">2011</xref>). In addition, exclusion of gluten from the diet can restore regular gut mucosa functions and mitigate gastrointestinal inflammation (Jianqin <italic>et al</italic>. <xref ref-type="bibr" rid="bib62">2015</xref>) and celiac disease (Anania <italic>et al</italic>. <xref ref-type="bibr" rid="bib2">2017</xref>; Brietzke <italic>et al</italic>. <xref ref-type="bibr" rid="bib18">2018</xref>), both of which could lead to the development of other autoimmune disorders like type I diabetes (Serena <italic>et al</italic>. <xref ref-type="bibr" rid="bib155">2015</xref>; Krzewska and Ben-Skowronek <xref ref-type="bibr" rid="bib75">2016</xref>).</p>
<p>There is also evidence that patients who have celiac disease, an autoimmune disorder triggered by gluten ingestion in genetically predisposed individuals, had a decreased representation of bifidobacteria species in their gut microbiota as compared to those of the healthy subjects (Golfetto <italic>et al</italic>. <xref ref-type="bibr" rid="bib54">2014</xref>). Several attempts have been made to supplement some bifidobacterial strains as a probiotics therapy for celiac disease (Smecuol <italic>et al</italic>. <xref ref-type="bibr" rid="bib157">2013</xref>; Klemenak <italic>et al</italic>. <xref ref-type="bibr" rid="bib71">2015</xref>; Quagliariello <italic>et al</italic>. <xref ref-type="bibr" rid="bib128">2016</xref>; Pinto-Sánchez <italic>et al</italic>. <xref ref-type="bibr" rid="bib119">2017</xref>). For instance, in a double-blind, randomised, placebo-controlled trial, administration of <italic>B. longum</italic> subsp. <italic>infantis</italic> NLS-SS to celiac disease patients for three weeks resulted in symptomatic improvement (Smecuol <italic>et al</italic>. <xref ref-type="bibr" rid="bib157">2013</xref>). Similarly, administration of two probiotic strains, <italic>B. breve</italic> B632 and BR03, suppressed tumour necrosis factor-alpha (TNF-α) production in celiac disease children on a gluten-free diet and such positive effect was reversed after three months of trial where probiotics supplementation had ceased (Klemenak <italic>et al</italic>. <xref ref-type="bibr" rid="bib71">2015</xref>). Moreover, some bifidobacterial strains (<italic>B. longum</italic> subsp. <italic>longum</italic> IATA-ES1 and <italic>B</italic>. bifidum IATA-ES2) have also been shown to degrade gliadin peptides into inactive peptides, thereby reducing the cytotoxic and inflammatory effects of gluten peptides (Laparra and Sanz <xref ref-type="bibr" rid="bib79">2010</xref>; Cinova <italic>et al</italic>. <xref ref-type="bibr" rid="bib26">2011</xref>).</p>
<p>Noteworthy, many of the strains exerting positive effects on gluten-mediated disorders are the commensal bacteria of the human gut and belong to HRB, albeit some non-HRB strain (<italic>B</italic>. <italic>animalis</italic> subsp. <italic>lactis</italic>) was also reported to have a positive effect (Lindfors <italic>et al</italic>. <xref ref-type="bibr" rid="bib86">2008</xref>). It is therefore implicated that the capability to degrade the potentially harmful food-derived opioid peptides could be a specific physiological function of HRB, explaining at least in part why HRB naturally inhabit the human gastrointestinal tract across the lifespan and how they contribute to human health. Indeed, HRB species were found to possess more potent degradative capabilities for human milk- and bovine milk-derived BCM-7 as well as wheat gluten-derived α-gliadorphin-7 (Sakurai <italic>et al</italic>. <xref ref-type="bibr" rid="bib149">2018</xref>). Specifically, infant-type HRB strains were reported to exert a relatively higher dipeptidyl peptidase IV — a proline-specific enzyme that can hydrolyse opioid peptides — activity than the other strains wherein certain strains of <italic>B. longum</italic> subsp. <italic>infantis</italic> and <italic>B. bifidum</italic> demonstrated the greatest degradative capabilities for all three food-derived opioid peptides. In contrast, the strains of non-HRB were inactive for the hydrolysis of food-derived opioid peptides (Sakurai <italic>et al</italic>. <xref ref-type="bibr" rid="bib149">2018</xref>). Taken together, these findings provide some clues on the possible role of HRB as prominent members of the human gut microbiota. It is implicated that HRB species could aid in the degradation of the potentially harmful food-derived opioid peptides, particularly the strains of infant-type HRB as of which these peptides are more potent to infants with immature gastrointestinal system, thereby contributing to host health.</p>
</sec>
<sec id="sec5-4">
<title>Production of aromatic lactic acids</title>
<p>Another vital feature of HRB species is their capability to produce tryptophan-derived indoles. Gut bacterial tryptophan metabolites have increasingly been recognised as an essential mediator in host physiology and may contribute to intestinal and systemic homeostasis (Tremaroli and Bäckhed <xref ref-type="bibr" rid="bib174">2012</xref>; Agus, Planchais and Sokol <xref ref-type="bibr" rid="bib1">2018</xref>). For instance, microbial tryptophan-derived indoles, including indole-3-acetic acid (IAA), indole-3-aldehyde (IAld), indole-3-lactic acid (ILA) and indole-3-propionic acid (IPA), have been reported to act as ligands of aryl hydrocarbon receptor (AhR) and may potentially improve gut barrier function and regulate gut mucosal immune responses (Hubbard <italic>et al</italic>. <xref ref-type="bibr" rid="bib57">2015</xref>; Cervantes-Barragan <italic>et al</italic>. <xref ref-type="bibr" rid="bib20">2017</xref>; Dodd <italic>et al</italic>. <xref ref-type="bibr" rid="bib32">2017</xref>; Wilck <italic>et al</italic>. <xref ref-type="bibr" rid="bib189">2017</xref>). ILA and IPA have also been identified as antioxidants and as free-radical scavengers (Chyan <italic>et al</italic>. <xref ref-type="bibr" rid="bib25">1999</xref>; Karbownik <italic>et al</italic>. <xref ref-type="bibr" rid="bib64">2006</xref>; Suzuki <italic>et al</italic>. <xref ref-type="bibr" rid="bib167">2013</xref>). In this regard, it seems likely that the production of tryptophan-derived indoles could be the precise mechanism deploys by HRB species in host-microbial interactions, contributing to their beneficial effects on human health.</p>
<p>This concept has been demonstrated in a recent study investigating the anti-inflammatory effect of ILA — a breastmilk tryptophan metabolite secreted by <italic>B. longum</italic> subsp. <italic>infantis</italic> — in the immature intestine (Meng <italic>et al</italic>. <xref ref-type="bibr" rid="bib97">2020</xref>). The study found that this tryptophan metabolite produced by an infant-type HRB strain <italic>B. longum</italic> subsp. <italic>infantis</italic> ATCC 15 697 interacts with AhR and reduces the inflammatory interleukin-8 (IL-8) response in immature but not mature intestinal enterocytes (Meng <italic>et al</italic>. <xref ref-type="bibr" rid="bib97">2020</xref>). Studies have shown that ILA is involved in host immune homeostasis via AhR activation, leading to reprogramming of immunoregulatory T cells and inflammatory T cells (Cervantes-Barragan <italic>et al</italic>. <xref ref-type="bibr" rid="bib20">2017</xref>; Lanz <italic>et al</italic>. <xref ref-type="bibr" rid="bib78">2017</xref>; Wilck <italic>et al</italic>. <xref ref-type="bibr" rid="bib189">2017</xref>). Such function would be beneficial for healthy growth, including the immune development and maturation, in infants.</p>
<p>Interestingly, in another recent report, ILA was found as the only tryptophan metabolite produced by bifidobacterial species; no others, including IPA, IAA, and IAld, were produced (Sakurai, Odamaki and Xiao <xref ref-type="bibr" rid="bib148">2019</xref>). Noteworthy, the species of infant-type HRB displayed the highest capacity for ILA production among which the strains of <italic>B. longum</italic> subsp. <italic>longum</italic>, <italic>B. longum</italic> subsp. <italic>infantis</italic>, <italic>B. breve</italic>, and <italic>B. bifidum</italic>, produced higher levels of ILA than other strains (Sakurai, Odamaki and Xiao <xref ref-type="bibr" rid="bib148">2019</xref>). Numerous studies have also demonstrated that infant-type HRB are particularly superior in producing ILA (Aragozzini <italic>et al</italic>. <xref ref-type="bibr" rid="bib4">1979</xref>; Russell <italic>et al</italic>. <xref ref-type="bibr" rid="bib140">2013</xref>; Ehrlich <italic>et al</italic>. <xref ref-type="bibr" rid="bib40">2018</xref>). Nevertheless, the exact biological role of ILA; how and why only limited species (infant-type HRB) are allowed to harbour in the human infant gut, remains unclear. Very recently, in a preprints, Laursen <italic>et al</italic>. <xref ref-type="bibr" rid="bib81">2020</xref> demonstrated that aromatic lactate dehydrogenase, an enzyme which was explicitly found in breastmilk-promoted <italic>Bifidobacterium</italic> species (infant-type HRB), is involved in the formation of aromatic lactic acid metabolites including ILA from aromatic amino acids. They also showed that stool concentrations of aromatic lactic acids are determined by the abundance of breast milk-promoted <italic>Bifidobacterium</italic> species harbouring the aromatic lactate dehydrogenase enzyme. ILA was pointed as a relevant early life AhR agonist and could be associated with intestinal and systemic homeostasis. ILA has been reported to have antimicrobial activity (Shigeno <italic>et al</italic>. <xref ref-type="bibr" rid="bib156">2018</xref>) in addition to hydrogen peroxide production as a by-product during tryptophan deamination (Dieuleveux, Lemarinier and Gueguen <xref ref-type="bibr" rid="bib30">1998</xref>), suggesting ILA production by infant-type HRB may contribute to their preponderance and competitiveness in the infant intestines. It is therefore implicated that bifidobacteria-derived ILA may have conserved roles in human health development. Taken together, these findings shed lights on the mechanism by which HRB, especially the infant-type, exert their adaptive abilities and beneficial properties in the human gut.</p>
</sec>
</sec>
<sec id="sec6">
<title>CONCLUDING REMARKS</title>
<p>Through more than a century after its discovery, evidence has indicated that bifidobacteria have coevolved with their respective hosts. Conversely, bifidobacterial species that naturally occur in the human gut, better known as HRB, have adapted to the human host and possess many unique physiological characteristics. This organism is seen as an essential member of the human gut microbiota across the lifespan, and is associated with human health. The acquisition of HRB species commences from birth, for which the bacteria are vertically transmitted from the mother's vaginal tract, gastrointestinal tract, breast milk, placenta and amniotic fluid to the infant. The studies, to date, have revealed that the persistence of infant-type HRB in the infant gut is attributed to their competitive abilities with regards to human milk (i.e. their ability to metabolise HMOs and tolerance to lysozyme). Noteworthy, infant-type HRB are naturally selected by human milk; they are genetically equipped and adapted to assimilate HMOs, explaining why the species of infant-type HRB have such a close relationship to the breast-fed infant. With a progressive reduction of breastfeeding and an increase of solid food intake, the species of HRB are then shifted from infant-type to adult-type. During adulthood, although their abundance is relatively low, HRB may still impact host overall health through their metabolic and physiological activities. In particular, adult-type HRB appear to possess a large amount of the gut-associated enzymatic arsenal dedicated to the metabolism of dietary plant polysaccharides and host-derived carbohydrates, thus enforcing the importance of HRB in facilitating the metabolism of complex carbohydrates that are not digested by human intestinal enzymes or by other gut bacteria. Besides, it has become clear that certain strains of HRB, particularly infant-type HRB, have a better functional capacity in various physiological activities, including the production of folate and ILA as well as degradation of food-derived opioid peptides. The studies discussed here shed lights on the role of HRB, particularly infant-type HRB in most of the cases, as members of human gut microbiota across the lifespan. Despite such findings, many potential physiological characteristics of HRB have yet to be explored. Furthermore, we still lack a comprehensive understanding of how HRB species interact with the human host and contribute to human health. More studies are thus needed to provide in-depth insight into the evolutionary scenario of this critical human gut commensal bacteria, which would, in turn, facilitate the selection of strains for application as human probiotics.</p>
</sec>
</body>
<back>
<ack id="ack1">
<title>ACKNOWLEDGEMENTS</title>
<p>The authors are grateful to all the researchers whom we cited in this review for their significant and valuable research. In particular, the authors would like express their deep gratitude to Dr Takane Katayama, Kyoto University, Dr Mikiyasu Sakanaka, Technical University of Denmark and Dr Francois Bernier, Next Generation Science Institute, Morinaga Milk Industries Co., Ltd. for their critical review of this manuscript.</p>
</ack>
<sec id="sec62065911994" sec-type="conflict">
<title>Conflict of interest</title>
<p>The authors, CBW, TO, and J-ZX are employees of Morinaga Milk Industry Co., Ltd., which has several probiotic products marketed worldwide. This does not alter our adherence to FEMS Microbiology Review policies on sharing data and materials.</p>
</sec>
<ref-list id="ref1">
<title>REFERENCES</title>
<ref id="bib1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Agus</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Planchais</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sokol</surname><given-names>H</given-names></name></person-group>
<article-title>Gut microbiota regulation of tryptophan metabolism in health and disease</article-title>. <source/>Cell Host Microbe. <year>2018</year>;<volume>23</volume>:<fpage>716</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">29902437</pub-id></mixed-citation>
</ref>
<ref id="bib2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Anania</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pacifico</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Olivero</surname><given-names>F</given-names></name><etal>et al</etal>.</person-group>
<article-title>Cardiometabolic risk factors in children with celiac disease on a gluten-free diet</article-title>. <source/>World J Clin Pediatr. <year>2017</year>;<volume>6</volume>:<fpage>143</fpage>.<pub-id pub-id-type="pmid">28828296</pub-id></mixed-citation>
</ref>
<ref id="bib3">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Andlid</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>D'Aimmo</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Jastrebova</surname><given-names>J</given-names></name></person-group>
<article-title>Folate and Bifidobacteria</article-title>. <source/>The Bifidobacteria and Related Organisms. <publisher-loc>Cambridge, Massachusetts, United States</publisher-loc>: <publisher-name>Academic Press Inc., Elsevier</publisher-name>, <year>2018</year>, <fpage>195</fpage>–<lpage>212</lpage>.</mixed-citation>
</ref>
<ref id="bib4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Aragozzini</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ferrari</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pacini</surname><given-names>N</given-names></name><etal>et al</etal>.</person-group>
<article-title>Indole-3-lactic acid as a tryptophan metabolite produced by <italic>Bifidobacterium</italic> spp</article-title>. <source/>Appl Environ Microbiol. <year>1979</year>;<volume>38</volume>:<fpage>544</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">533277</pub-id></mixed-citation>
</ref>
<ref id="bib5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Arboleya</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bottacini</surname><given-names>F</given-names></name>, <name name-style="western"><surname>O'Connell-Motherway</surname><given-names>M</given-names></name><etal>et al</etal>.</person-group>
<article-title>Gene-trait matching across the <italic>Bifidobacterium longum</italic> pan-genome reveals considerable diversity in carbohydrate catabolism among human infant strains</article-title>. <source/>BMC Genomics. <year>2018</year>;<volume>19</volume>:<fpage>33</fpage>.<pub-id pub-id-type="pmid">29310579</pub-id></mixed-citation>
</ref>
<ref id="bib6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Arboleya</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Watkins</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Stanton</surname><given-names>C</given-names></name><etal>et al</etal>.</person-group>
<article-title>Gut bifidobacteria populations in human health and aging</article-title>. <source/>Front Microbiol. <year>2016</year>;<volume>7</volume>:<fpage>1204</fpage>.<pub-id pub-id-type="pmid">27594848</pub-id></mixed-citation>
</ref>
<ref id="bib7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Asakuma</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hatakeyama</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Urashima</surname><given-names>T</given-names></name><etal>et al</etal>.</person-group>
<article-title>Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria</article-title>. <source/>J Biol Chem. <year>2011</year>;<volume>286</volume>:<fpage>34583</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">21832085</pub-id></mixed-citation>
</ref>
<ref id="bib8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ashida</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Miyake</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kiyohara</surname><given-names>M</given-names></name><etal>et al</etal>.</person-group>
<article-title>Two distinct α-L-fucosidases from <italic>Bifidobacterium bifidum</italic> are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates</article-title>. <source/>Glycobiology. <year>2009</year>;<volume>19</volume>:<fpage>1010</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">19520709</pub-id></mixed-citation>
</ref>
<ref id="bib9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Aufreiter</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gregory</surname><given-names>JF</given-names><suffix>III</suffix></name>, <name name-style="western"><surname>Pfeiffer</surname><given-names>CM</given-names></name><etal>et al</etal>.</person-group>
<article-title>Folate is absorbed across the colon of adults: evidence from cecal infusion of 13C-labeled [6S]-5-formyltetrahydrofolic acid</article-title>. <source/>Am J Clin Nutr. <year>2009</year>;<volume>90</volume>:<fpage>116</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">19439459</pub-id></mixed-citation>
</ref>
<ref id="bib10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ballard</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Morrow</surname><given-names>AL</given-names></name></person-group>
<article-title>Human milk composition: nutrients and bioactive factors</article-title>. <source/>Pediatr Clin. <year>2013</year>;<volume>60</volume>:<fpage>49</fpage>–<lpage>74</lpage>.</mixed-citation>
</ref>
<ref id="bib11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Barrangou</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Briczinski</surname><given-names>EP</given-names></name>, <name name-style="western"><surname>Traeger</surname><given-names>LL</given-names></name><etal>et al</etal>.</person-group>
<article-title>Comparison of the complete genome sequences of <italic>Bifidobacterium</italic><italic>animalis</italic> subsp. <italic>lactis</italic> DSM 10140 and Bl-04</article-title>. <source/>J Bacteriol. <year>2009</year>;<volume>191</volume>:<fpage>4144</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">19376856</pub-id></mixed-citation>
</ref>
<ref id="bib12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Biavati</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Scardovi</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>WEC</given-names></name></person-group>
<article-title>Electrophoretic patterns of proteins in the genus <italic>Bifidobacterium</italic> and proposal of four new species</article-title>. <source/>Int J Syst Evol Microbiol. <year>1982</year>;<volume>32</volume>:<fpage>358</fpage>–<lpage>73</lpage>.</mixed-citation>
</ref>
<ref id="bib13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Biavati</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Vescovo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Torriani</surname><given-names>S</given-names></name><etal>et al</etal>.</person-group>
<article-title>Bifidobacteria: history, ecology, physiology and applications</article-title>. <source/>Ann Microbiol. <year>2000</year>;<volume>50</volume>:<fpage>117</fpage>–<lpage>32</lpage>.</mixed-citation>
</ref>
<ref id="bib14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bode</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jantscher-Krenn</surname><given-names>E</given-names></name></person-group>
<article-title>Structure-function relationships of human milk oligosaccharides</article-title>. <source/>Adv Nutr. <year>2012</year>;<volume>3</volume>:<fpage>383S</fpage>–<lpage>91S</lpage>.<pub-id pub-id-type="pmid">22585916</pub-id></mixed-citation>
</ref>
<ref id="bib16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bottacini</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Morrissey</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Esteban-Torres</surname><given-names>M</given-names></name><etal>et al</etal>.</person-group>
<article-title>Comparative genomics and genotype-phenotype associations in <italic>Bifidobacterium breve</italic></article-title>. <source/>Sci Rep. <year>2018</year>;<volume>8</volume>:<fpage>1</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">29311619</pub-id></mixed-citation>
</ref>
<ref id="bib17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Brantl</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Teschemacher</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bläsig</surname><given-names>J</given-names></name><etal>et al</etal>.</person-group>
<article-title>Opioid activities of β-casomorphins</article-title>. <source/>Life Sci. <year>1981</year>;<volume>28</volume>:<fpage>1903</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">6265721</pub-id></mixed-citation>
</ref>
<ref id="bib18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Brietzke</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cerqueira</surname><given-names>RO</given-names></name>, <name name-style="western"><surname>Mansur</surname><given-names>RB</given-names></name><etal>et al</etal>.</person-group>
<article-title>Gluten related illnesses and severe mental disorders: a comprehensive review</article-title>. <source/>Neurosci Biobehav Rev. <year>2018</year>;<volume>84</volume>:<fpage>368</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">28830676</pub-id></mixed-citation>
</ref>
<ref id="bib19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bunesova</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Lacroix</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Schwab</surname><given-names>C</given-names></name></person-group>
<article-title>Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense</article-title>. <source/>BMC Microbiol. <year>2016</year>;<volume>16</volume>:<fpage>248</fpage>.<pub-id pub-id-type="pmid">27782805</pub-id></mixed-citation>
</ref>
<ref id="bib15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Böger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>van Leeuwen</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Lammerts van Bueren</surname><given-names>A</given-names></name><etal>et al</etal>.</person-group>
<article-title>Structural identity of galactooligosaccharide molecules selectively utilized by single cultures of probiotic bacterial strains</article-title>. <source/>J Agric Food Chem. <year>2019</year>;<volume>67</volume>:<fpage>13969</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">31747272</pub-id></mixed-citation>
</ref>
<ref id="bib20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cervantes-Barragan</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chai</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Tianero</surname><given-names>MD</given-names></name><etal>et al</etal>.</person-group>
<article-title>Lactobacillus reuteri induces gut intraepithelial CD4+ CD8αα+ T cells</article-title>. <source/>Science (80-). <year>2017</year>;<volume>357</volume>:<fpage>806</fpage>–<lpage>10</lpage>.</mixed-citation>
</ref>
<ref id="bib21">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name></person-group>
<article-title>Human milk oligosaccharides (HMOS): structure, function, and enzyme-catalyzed synthesis</article-title>. <source/>Advances in Carbohydrate Chemistry and Biochemistry. Vol <volume>72</volume>, <publisher-loc>Cambridge, Massachusetts, United States</publisher-loc>: <publisher-name>Academic Press Inc., Elsevier</publisher-name>, <year>2015</year>, <fpage>113</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">26613816</pub-id></mixed-citation>
</ref>
<ref id="bib22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chia</surname><given-names>JSJ</given-names></name>, <name name-style="western"><surname>McRae</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Kukuljan</surname><given-names>S</given-names></name><etal>et al</etal>.</person-group>
<article-title>A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes</article-title>. <source/>Nutr Diabetes. <year>2017</year>;<volume>7</volume>:<fpage>e274</fpage>.<pub-id pub-id-type="pmid">28504710</pub-id></mixed-citation>
</ref>
<ref id="bib23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>S-W</given-names></name>, <name name-style="western"><surname>Mason</surname><given-names>JB</given-names></name></person-group>
<article-title>Folate and carcinogenesis: an integrated scheme</article-title>. <source/>J Nutr. <year>2000</year>;<volume>130</volume>:<fpage>129</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">10720158</pub-id></mixed-citation>
</ref>
<ref id="bib24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Prince</surname><given-names>AL</given-names></name><etal>et al</etal>.</person-group>
<article-title>Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery</article-title>. <source/>Nat Med. <year>2017</year>;<volume>23</volume>:<fpage>314</fpage>.<pub-id pub-id-type="pmid">28112736</pub-id></mixed-citation>
</ref>
<ref id="bib25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chyan</surname><given-names>Y-J</given-names></name>, <name name-style="western"><surname>Poeggeler</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Omar</surname><given-names>RA</given-names></name><etal>et al</etal>.</person-group>
<article-title>Potent neuroprotective properties against the Alzheimer β-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid</article-title>. <source/>J Biol Chem. <year>1999</year>;<volume>274</volume>:<fpage>21937</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">10419516</pub-id></mixed-citation>
</ref>
<ref id="bib26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cinova</surname><given-names>J</given-names></name>, <name name-style="western"><surname>De Palma</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Stepankova</surname><given-names>R</given-names></name><etal>et al</etal>.</person-group>
<article-title>Role of intestinal bacteria in gliadin-induced changes in intestinal mucosa: study in germ-free rats</article-title>. <source/>PLoS One. <year>2011</year>;<volume>6</volume>:<fpage>e16169</fpage>.<pub-id pub-id-type="pmid">21249146</pub-id></mixed-citation>
</ref>
<ref id="bib27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Collado</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Rautava</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Aakko</surname><given-names>J</given-names></name><etal>et al</etal>.</person-group>
<article-title>Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid</article-title>. <source/>Sci Rep. <year>2016</year>;<volume>6</volume>:<fpage>23129</fpage>.<pub-id pub-id-type="pmid">27001291</pub-id></mixed-citation>
</ref>
<ref id="bib28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>D'Aimmo</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Mattarelli</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Biavati</surname><given-names>B</given-names></name><etal>et al</etal>.</person-group>
<article-title>The potential of bifidobacteria as a source of natural folate</article-title>. <source/>J Appl Microbiol. <year>2012</year>;<volume>112</volume>:<fpage>975</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">22335359</pub-id></mixed-citation>
</ref>
<ref id="bib29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>D'Aimmo</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Modesto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mattarelli</surname><given-names>P</given-names></name><etal>et al</etal>.</person-group>
<article-title>Biosynthesis and cellular content of folate in bifidobacteria across host species with different diets</article-title>. <source/>Anaerobe. <year>2014</year>;<volume>30</volume>:<fpage>169</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">25312826</pub-id></mixed-citation>
</ref>
<ref id="bib53">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>de Goffau</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Lager</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sovio</surname><given-names>U</given-names></name><etal>et al</etal>.</person-group>
<article-title>Human placenta has no microbiome but can contain potential pathogens</article-title>. <source/>Nature. <year>2019</year>;<volume>572</volume>:<fpage>329</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">31367035</pub-id></mixed-citation>
</ref>
<ref id="bib30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dieuleveux</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Lemarinier</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gueguen</surname><given-names>M</given-names></name></person-group>
<article-title>Antimicrobial spectrum and target site of D-3-phenyllactic acid</article-title>. <source/>Int J Food Microbiol. <year>1998</year>;<volume>40</volume>:<fpage>177</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">9620125</pub-id></mixed-citation>
</ref>
<ref id="bib32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dodd</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Spitzer</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Van Treuren</surname><given-names>W</given-names></name><etal>et al</etal>.</person-group>
<article-title>A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites</article-title>. <source/>Nature. <year>2017</year>;<volume>551</volume>:<fpage>648</fpage>.<pub-id pub-id-type="pmid">29168502</pub-id></mixed-citation>
</ref>
<ref id="bib33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Xin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Jian</surname><given-names>W</given-names></name><etal>et al</etal>.</person-group>
<article-title>
<italic>Bifidobacterium thermacidophilum</italic>sp. nov., isolated from an anaerobic digester</article-title>. <source/>Int J Syst Evol Microbiol. <year>2000</year>;<volume>50</volume>:<fpage>119</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">10826794</pub-id></mixed-citation>
</ref>
<ref id="bib34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Duranti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Milani</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lugli</surname><given-names>GA</given-names></name><etal>et al</etal>.</person-group>
<article-title>Evaluation of genetic diversity among strains of the human gut commensal <italic>Bifidobacterium adolescentis</italic></article-title>. <source/>Sci Rep. <year>2016</year>;<volume>6</volume>:<fpage>23971</fpage>.<pub-id pub-id-type="pmid">27035119</pub-id></mixed-citation>
</ref>
<ref id="bib35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Duranti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Turroni</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lugli</surname><given-names>GA</given-names></name><etal>et al</etal>.</person-group>
<article-title>Genomic characterization and transcriptional studies of the starch-utilizing strain <italic>Bifidobacterium</italic> adolescentis 22 L</article-title>. <source/>Appl Environ Microbiol. <year>2014</year>;<volume>80</volume>:<fpage>6080</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">25063659</pub-id></mixed-citation>
</ref>
<ref id="bib36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Eckel</surname><given-names>VPL</given-names></name>, <name name-style="western"><surname>Ziegler</surname><given-names>L-M</given-names></name>, <name name-style="western"><surname>Vogel</surname><given-names>RF</given-names></name><etal>et al</etal>.</person-group>
<article-title>
<italic>Bifidobacterium tibiigranuli</italic> sp. nov. isolated from homemade water kefir</article-title>. <source/>Int J Syst Evol Microbiol. <year>2019</year>:<fpage>ijsem003936</fpage>.</mixed-citation>
</ref>
<ref id="bib37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Egan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Motherway</surname><given-names>MO</given-names></name><etal>et al</etal>.</person-group>
<article-title>Glycosulfatase-encoding gene cluster in <italic>Bifidobacterium breve</italic> UCC2003</article-title>. <source/>Appl Environ Microbiol. <year>2016</year>;<volume>82</volume>:<fpage>6611</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">27590817</pub-id></mixed-citation>
</ref>
<ref id="bib38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Egan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Motherway</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Kilcoyne</surname><given-names>M</given-names></name><etal>et al</etal>.</person-group>
<article-title>Cross-feeding by<italic>Bifidobacterium breve</italic> UCC2003 during co-cultivation with <italic>Bifidobacterium bifidum</italic> PRL2010 in a mucin-based medium</article-title>. <source/>BMC Microbiol. <year>2014a</year>;<volume>14</volume>:<fpage>282</fpage>.<pub-id pub-id-type="pmid">25420416</pub-id></mixed-citation>
</ref>
<ref id="bib39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Egan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Motherway</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Ventura</surname><given-names>M</given-names></name><etal>et al</etal>.</person-group>
<article-title>Metabolism of sialic acid by<italic>Bifidobacterium breve</italic>UCC2003</article-title>. <source/>Appl Environ Microbiol. <year>2014b</year>;<volume>80</volume>:<fpage>4414</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">24814790</pub-id></mixed-citation>
</ref>
<ref id="bib40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ehrlich</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Henrick</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Pacheco</surname><given-names>A</given-names></name><etal>et al</etal>.</person-group>
<article-title>
<italic>Bifidobacterium</italic> grown on human milk oligosaccharides produce tryptophan metabolite Indole-3-lactic acid that significantly decreases inflammation in intestinal cells in vitro</article-title>. <source/>FASEB J. <year>2018</year>;<volume>32</volume>:<fpage>lb359</fpage>.</mixed-citation>
</ref>
<ref id="bib41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Favier</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Vaughan</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>De Vos</surname><given-names>WM</given-names></name><etal>et al</etal>.</person-group>
<article-title>Molecular monitoring of succession of bacterial communities in human neonates</article-title>. <source/>Appl Environ Microbiol. <year>2002</year>;<volume>68</volume>:<fpage>219</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">11772630</pub-id></mixed-citation>
</ref>
<ref id="bib42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ferretti</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pasolli</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Tett</surname><given-names>A</given-names></name><etal>et al</etal>.</person-group>
<article-title>Mother-to-infant microbial transmission from different body sites shapes the developing infant gut microbiome</article-title>. <source/>Cell Host Microbe. <year>2018</year>;<volume>24</volume>:<fpage>133</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="pmid">30001516</pub-id></mixed-citation>
</ref>
<ref id="bib43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fiedorowicz</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kaczmarski</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cieślińska</surname><given-names>A</given-names></name><etal>et al</etal>.</person-group>
<article-title>β-casomorphin-7 alters μ-opioid receptor and dipeptidyl peptidase IV genes expression in children with atopic dermatitis</article-title>. <source/>Peptides. <year>2014</year>;<volume>62</volume>:<fpage>144</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">25281794</pub-id></mixed-citation>
</ref>
<ref id="bib44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Field</surname><given-names>CJ</given-names></name></person-group>
<article-title>The immunological components of human milk and their effect on immune development in infants</article-title>. <source/>J Nutr. <year>2005</year>;<volume>135</volume>:<fpage>1</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">15623823</pub-id></mixed-citation>
</ref>
<ref id="bib45">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Freitas</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Hill</surname><given-names>JE</given-names></name></person-group>
<article-title>Bifidobacteria isolated from vaginal and gut microbiomes are indistinguishable by comparative genomics</article-title>. <source/>PLoS One. <year>2018</year>;<volume>13</volume>:<fpage>e0196290</fpage>.<pub-id pub-id-type="pmid">29684056</pub-id></mixed-citation>
</ref>
<ref id="bib46">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fujita</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Oura</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Nagamine</surname><given-names>N</given-names></name><etal>et al</etal>.</person-group>
<article-title>Identification and molecular cloning of a novel glycoside hydrolase family of core 1 type O-glycan-specific endo-α-N-acetylgalactosaminidase from <italic>Bifidobacterium longum</italic></article-title>. <source/>J Biol Chem. <year>2005</year>;<volume>280</volume>:<fpage>37415</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">16141207</pub-id></mixed-citation>
</ref>
<ref id="bib47">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fujita</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sakamoto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kaneko</surname><given-names>S</given-names></name><etal>et al</etal>.</person-group>
<article-title>Degradative enzymes for type II arabinogalactan side chains in <italic>Bifidobacterium longum</italic> subsp. <italic>longum</italic></article-title>. <source/>Appl Microbiol Biotechnol. <year>2019</year>;<volume>103</volume>:<fpage>1299</fpage>–<lpage>310</lpage>.<pub-id pub-id-type="pmid">30564851</pub-id></mixed-citation>
</ref>
<ref id="bib48">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gagnon</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kheadr</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Le Blay</surname><given-names>G</given-names></name><etal>et al</etal>.</person-group>
<article-title>In vitro inhibition of Escherichia coli O157: H7 by bifidobacterial strains of human origin</article-title>. <source/>Int J Food Microbiol. <year>2004</year>;<volume>92</volume>:<fpage>69</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="pmid">15033269</pub-id></mixed-citation>
</ref>
<ref id="bib49">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Garrido</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Barile</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Mills</surname><given-names>DA</given-names></name></person-group>
<article-title>A molecular basis for bifidobacterial enrichment in the infant gastrointestinal tract</article-title>. <source/>Adv Nutr. <year>2012</year>;<volume>3</volume>:<fpage>415S</fpage>–<lpage>21S</lpage>.<pub-id pub-id-type="pmid">22585920</pub-id></mixed-citation>
</ref>
<ref id="bib50">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Garrido</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>German</surname><given-names>JB</given-names></name><etal>et al</etal>.</person-group>
<article-title>Oligosaccharide binding proteins from <italic>Bifidobacterium longum</italic> subsp. <italic>infantis</italic> reveal a preference for host glycans</article-title>. <source/>PLoS One. <year>2011</year>;<volume>6</volume>:<fpage>1</fpage>–<lpage>13</lpage>.</mixed-citation>
</ref>
<ref id="bib51">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Garrido</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ruiz-Moyano</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kirmiz</surname><given-names>N</given-names></name><etal>et al</etal>.</person-group>
<article-title>A novel gene cluster allows preferential utilization of fucosylated milk oligosaccharides in <italic>Bifidobacterium longum</italic> subsp. <italic>longum</italic> SC596</article-title>. <source/>Sci Rep. <year>2016</year>;<volume>6</volume>:<fpage>35045</fpage>.<pub-id pub-id-type="pmid">27756904</pub-id></mixed-citation>
</ref>
<ref id="bib52">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Garrido</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ruiz-Moyano</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lemay</surname><given-names>DG</given-names></name><etal>et al</etal>.</person-group>
<article-title>Comparative transcriptomics reveals key differences in the response to milk oligosaccharides of infant gut-associated bifidobacteria</article-title>. <source/>Sci Rep. <year>2015</year>;<volume>5</volume>:<fpage>13517</fpage>.<pub-id pub-id-type="pmid">26337101</pub-id></mixed-citation>
</ref>
<ref id="bib54">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Golfetto</surname><given-names>L</given-names></name>, <name name-style="western"><surname>de Senna</surname><given-names>FD</given-names></name>, <name name-style="western"><surname>Hermes</surname><given-names>J</given-names></name><etal>et al</etal>.</person-group>
<article-title>Lower bifidobacteria counts in adult patients with celiac disease on a gluten-free diet</article-title>. <source/>Arq Gastroenterol. <year>2014</year>;<volume>51</volume>:<fpage>139</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="pmid">25003267</pub-id></mixed-citation>
</ref>
<ref id="bib55">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gotoh</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Katoh</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sakanaka</surname><given-names>M</given-names></name><etal>et al</etal>.</person-group>
<article-title>Sharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with <italic>Bifidobacterium bifidum</italic></article-title>. <source/>Sci Rep. <year>2018</year>;<volume>8</volume>:<fpage>13958</fpage>.<pub-id pub-id-type="pmid">30228375</pub-id></mixed-citation>
</ref>
<ref id="bib56">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gueimonde</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Laitinen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Salminen</surname><given-names>S</given-names></name><etal>et al</etal>.</person-group>
<article-title>Breast milk: a source of bifidobacteria for infant gut development and maturation?</article-title>
<source/>Neonatology. <year>2007</year>;<volume>92</volume>:<fpage>64</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">17596738</pub-id></mixed-citation>
</ref>
<ref id="bib57">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hubbard</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Murray</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Bisson</surname><given-names>WH</given-names></name><etal>et al</etal>.</person-group>
<article-title>Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles</article-title>. <source/>Sci Rep. <year>2015</year>;<volume>5</volume>:<fpage>12689</fpage>.<pub-id pub-id-type="pmid">26235394</pub-id></mixed-citation>
</ref>
<ref id="bib58">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ishikawa</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Matsuki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kubota</surname><given-names>H</given-names></name><etal>et al</etal>.</person-group>
<article-title>Ethnic diversity of gut microbiota: species characterization of Bacteroides fragilis group and genus <italic>Bifidobacterium</italic>in healthy Belgian adults, and comparison with data from Japanese subjects</article-title>. <source/>J Biosci Bioeng. <year>2013</year>;<volume>116</volume>:<fpage>265</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="pmid">23522670</pub-id></mixed-citation>
</ref>
<ref id="bib59">
<mixed-citation publication-type="other">
<person-group person-group-type="author"><name name-style="western"><surname>Jacob</surname><given-names>RA</given-names></name></person-group>
<article-title>Folate, DNA methylation, and gene expression: factors of nature and nurture</article-title>. <year>2000</year>.</mixed-citation>
</ref>
<ref id="bib60">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>James</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bottacini</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Contreras</surname><given-names>JIS</given-names></name><etal>et al</etal>.</person-group>
<article-title>Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal</article-title>. <source/>Sci Rep. <year>2019</year>;<volume>9</volume>:<fpage>1</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">30626917</pub-id></mixed-citation>
</ref>
<ref id="bib61">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>James</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Motherway</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Bottacini</surname><given-names>F</given-names></name><etal>et al</etal>.</person-group>
<article-title>
<italic>Bifidobacterium breve</italic> UCC2003 metabolises the human milk oligosaccharides lacto-N-tetraose and lacto-N-neo-tetraose through overlapping, yet distinct pathways</article-title>. <source/>Sci Rep. <year>2016</year>;<volume>6</volume>:<fpage>38560</fpage>.<pub-id pub-id-type="pmid">27929046</pub-id></mixed-citation>
</ref>
<ref id="bib62">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jianqin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Leiming</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>X</given-names></name><etal>et al</etal>.</person-group>
<article-title>Effects of milk containing only A2 beta casein versus milk containing both A1 and A2 beta casein proteins on gastrointestinal physiology, symptoms of discomfort, and cognitive behavior of people with self-reported intolerance to traditional cows’ milk</article-title>. <source/>Nutr J. <year>2015</year>;<volume>15</volume>:<fpage>35</fpage>.</mixed-citation>
</ref>
<ref id="bib63">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jost</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Lacroix</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Braegger</surname><given-names>CP</given-names></name><etal>et al</etal>.</person-group>
<article-title>Vertical mother–neonate transfer of maternal gut bacteria via breastfeeding</article-title>. <source/>Environ Microbiol. <year>2014</year>;<volume>16</volume>:<fpage>2891</fpage>–<lpage>904</lpage>.<pub-id pub-id-type="pmid">24033881</pub-id></mixed-citation>
</ref>
<ref id="bib64">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Karbownik</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Stasiak</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zygmunt</surname><given-names>A</given-names></name><etal>et al</etal>.</person-group>
<article-title>Protective effects of melatonin and indole-3-propionic acid against lipid peroxidation, caused by potassium bromate in the rat kidney</article-title>. <source/>Cell Biochem Funct Cell Biochem its Modul by Act agents or Dis. <year>2006</year>;<volume>24</volume>:<fpage>483</fpage>–<lpage>9</lpage>.</mixed-citation>
</ref>
<ref id="bib65">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Katayama</surname><given-names>T</given-names></name></person-group>
<article-title>Host-derived glycans serve as selected nutrients for the gut microbe: human milk oligosaccharides and bifidobacteria</article-title>. <source/>Biosci Biotechnol Biochem. <year>2016</year>;<volume>80</volume>:<fpage>621</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">26838671</pub-id></mixed-citation>
</ref>
<ref id="bib66">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kato</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Odamaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mitsuyama</surname><given-names>E</given-names></name><etal>et al</etal>.</person-group>
<article-title>Age-related changes in the composition of gut <italic>Bifidobacterium</italic>species</article-title>. <source/>Curr Microbiol. <year>2017</year>;<volume>74</volume>:<fpage>987</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="pmid">28593350</pub-id></mixed-citation>
</ref>
<ref id="bib67">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Bottacini</surname><given-names>F</given-names></name>, <name name-style="western"><surname>O'Callaghan</surname><given-names>J</given-names></name><etal>et al</etal>.</person-group>
<article-title>Glycoside hydrolase family 13 α-glucosidases encoded by <italic>Bifidobacterium breve</italic> UCC2003; a comparative analysis of function, structure and phylogeny</article-title>. <source/>Int J Food Microbiol. <year>2016</year>;<volume>224</volume>:<fpage>55</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">26967000</pub-id></mixed-citation>
</ref>
<ref id="bib68">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kirmiz</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Robinson</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>IM</given-names></name><etal>et al</etal>.</person-group>
<article-title>Milk glycans and their interaction with the infant-gut microbiota</article-title>. <source/>Annu Rev Food Sci Technol. <year>2018</year>;<volume>9</volume>:<fpage>429</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">29580136</pub-id></mixed-citation>
</ref>
<ref id="bib69">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kitaoka</surname><given-names>M</given-names></name></person-group>
<article-title>Bifidobacterial enzymes involved in the metabolism of human milk oligosaccharides</article-title>. <source/>Adv Nutr. <year>2012</year>;<volume>3</volume>:<fpage>422S</fpage>–<lpage>9S</lpage>.<pub-id pub-id-type="pmid">22585921</pub-id></mixed-citation>
</ref>
<ref id="bib70">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kiyohara</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nakatomi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kurihara</surname><given-names>S</given-names></name><etal>et al</etal>.</person-group>
<article-title>α-N-acetylgalactosaminidase from infant-associated bifidobacteria belonging to novel glycoside hydrolase family 129 is implicated in alternative mucin degradation pathway</article-title>. <source/>J Biol Chem. <year>2012</year>;<volume>287</volume>:<fpage>693</fpage>–<lpage>700</lpage>.<pub-id pub-id-type="pmid">22090027</pub-id></mixed-citation>
</ref>
<ref id="bib71">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Klemenak</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dolinšek</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Langerholc</surname><given-names>T</given-names></name><etal>et al</etal>.</person-group>
<article-title>Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease</article-title>. <source/>Dig Dis Sci. <year>2015</year>;<volume>60</volume>:<fpage>3386</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">26134988</pub-id></mixed-citation>
</ref>
<ref id="bib72">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kobata</surname><given-names>A</given-names></name></person-group>
<article-title>Structures and application of oligosaccharides in human milk</article-title>. <source/>Proc Japan Acad Ser B. <year>2010</year>;<volume>86</volume>:<fpage>731</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="pmid">20689231</pub-id></mixed-citation>
</ref>
<ref id="bib73">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Komeno</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hayamizu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fujita</surname><given-names>K</given-names></name><etal>et al</etal>.</person-group>
<article-title>Two novel α-L-arabinofuranosidases from <italic>Bifidobacterium longum</italic> subsp. <italic>longum</italic> belonging to glycoside hydrolase family 43 cooperatively degrade arabinan</article-title>. <source/>Appl Environ Microbiol. <year>2019</year>;<volume>85</volume>:<fpage>e02582</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">30635377</pub-id></mixed-citation>
</ref>
<ref id="bib74">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kordy</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gaufin</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mwangi</surname><given-names>M</given-names></name><etal>et al</etal>.</person-group>
<article-title>Contributions to human breast milk microbiome and enteromammary transfer of <italic>Bifidobacterium breve</italic></article-title>. <source/>PLoS One. <year>2020</year>;<volume>15</volume>:<fpage>e0219633</fpage>.<pub-id pub-id-type="pmid">31990909</pub-id></mixed-citation>
</ref>
<ref id="bib75">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Krzewska</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ben-Skowronek</surname><given-names>I</given-names></name></person-group>
<article-title>Effect of associated autoimmune diseases on type 1 diabetes mellitus incidence and metabolic control in children and adolescents</article-title>. <source/>Biomed Res Int. <year>2016</year>;<volume>2016</volume>.</mixed-citation>
</ref>
<ref id="bib76">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kunz</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rudloff</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Baier</surname><given-names>W</given-names></name><etal>et al</etal>.</person-group>
<article-title>Oligosaccharides in human milk: structural, functional, and metabolic aspects</article-title>. <source/>Annu Rev Nutr. <year>2000</year>;<volume>20</volume>:<fpage>699</fpage>–<lpage>722</lpage>.<pub-id pub-id-type="pmid">10940350</pub-id></mixed-citation>
</ref>
<ref id="bib77">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lamendella</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Santo Domingo</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Kelty</surname><given-names>C</given-names></name><etal>et al</etal>.</person-group>
<article-title>Bifidobacteria in feces and environmental waters</article-title>. <source/>Appl Environ Microbiol. <year>2008</year>;<volume>74</volume>:<fpage>575</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">17993557</pub-id></mixed-citation>
</ref>
<ref id="bib78">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lanz</surname><given-names>TV</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mohapatra</surname><given-names>SR</given-names></name><etal>et al</etal>.</person-group>
<article-title>Suppression of Th1 differentiation by tryptophan supplementation in vivo</article-title>. <source/>Amino Acids. <year>2017</year>;<volume>49</volume>:<fpage>1169</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">28421297</pub-id></mixed-citation>
</ref>
<ref id="bib79">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Laparra</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Sanz</surname><given-names>Y</given-names></name></person-group>
<article-title>Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion</article-title>. <source/>J Cell Biochem. <year>2010</year>;<volume>109</volume>:<fpage>801</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">20052669</pub-id></mixed-citation>
</ref>
<ref id="bib80">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Laureys</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Cnockaert</surname><given-names>M</given-names></name>, <name name-style="western"><surname>De Vuyst</surname><given-names>L</given-names></name><etal>et al</etal>.</person-group>
<article-title>
<italic>Bifidobacterium aquikefiri</italic> sp. nov., isolated from water kefir</article-title>. <source/>Int J Syst Evol Microbiol. <year>2016</year>;<volume>66</volume>:<fpage>1281</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">26739269</pub-id></mixed-citation>
</ref>
<ref id="bib81">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Laursen</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Sakanaka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>von Burg</surname><given-names>N</given-names></name><etal>et al</etal>.</person-group>
<article-title>Breastmilk-promoted bifidobacteria produce aromatic lactic acids in the infant gut</article-title>. <source/>bioRxiv. <year>2020</year>.</mixed-citation>
</ref>
<ref id="bib82">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lawson</surname><given-names>MAE</given-names></name>, <name name-style="western"><surname>O'Neill</surname><given-names>IJ</given-names></name>, <name name-style="western"><surname>Kujawska</surname><given-names>M</given-names></name><etal>et al</etal>.</person-group>
<article-title>Breast milk-derived human milk oligosaccharides promote <italic>Bifidobacterium</italic> interactions within a single ecosystem</article-title>. <source/>ISME J. <year>2019</year>:<volume>14</volume>:<fpage>635</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="pmid">31740752</pub-id></mixed-citation>
</ref>
<ref id="bib83">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>LeBlanc</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Milani</surname><given-names>C</given-names></name>, <name name-style="western"><surname>De Giori</surname><given-names>GS</given-names></name><etal>et al</etal>.</person-group>
<article-title>Bacteria as vitamin suppliers to their host: a gut microbiota perspective</article-title>. <source/>Curr Opin Biotechnol. <year>2013</year>;<volume>24</volume>:<fpage>160</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">22940212</pub-id></mixed-citation>
</ref>
<ref id="bib31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Le Doare</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Holder</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bassett</surname><given-names>A</given-names></name><etal>et al</etal>.</person-group>
<article-title>Mother's milk: A purposeful contribution to the development of the infant microbiota and immunity</article-title>. <source/>Front Immunol. <year>2018</year>;<volume>9</volume>:<fpage>361</fpage>.<pub-id pub-id-type="pmid">29599768</pub-id></mixed-citation>
</ref>
<ref id="bib84">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Lewis</surname><given-names>ZT</given-names></name>, <name name-style="western"><surname>Mills</surname><given-names>DA</given-names></name></person-group>
<article-title>Differential establishment of bifidobacteria in the breastfed infant gut</article-title>. <source/>Intestinal Microbiome: Functional Aspects in Health and Disease. Vol <volume>88</volume>, <publisher-loc>Karger AG, Basel</publisher-loc>: <publisher-name>Karger Publishers</publisher-name>, <year>2017</year>, <fpage>149</fpage>–<lpage>60</lpage>.</mixed-citation>
</ref>
<ref id="bib85">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>L</given-names></name><etal>et al</etal>.</person-group>
<article-title>The impacts of delivery mode on infant's oral microflora</article-title>. <source/>Sci Rep. <year>2018</year>;<volume>8</volume>:<fpage>11938</fpage>.<pub-id pub-id-type="pmid">30093722</pub-id></mixed-citation>
</ref>
<ref id="bib86">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lindfors</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Blomqvist</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Juuti‐Uusitalo</surname><given-names>K</given-names></name><etal>et al</etal>.</person-group>
<article-title>Live probiotic<italic>Bifidobacterium lactis</italic>bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture</article-title>. <source/>Clin Exp Immunol. <year>2008</year>;<volume>152</volume>:<fpage>552</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">18422736</pub-id></mixed-citation>
</ref>
<ref id="bib87">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Udenigwe</surname><given-names>CC</given-names></name></person-group>
<article-title>Role of food‐derived opioid peptides in the central nervous and gastrointestinal systems</article-title>. <source/>J Food Biochem. <year>2019</year>;<volume>43</volume>:<fpage>e12629</fpage>.<pub-id pub-id-type="pmid">31353498</pub-id></mixed-citation>
</ref>
<ref id="bib88">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>LoCascio</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Desai</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sela</surname><given-names>DA</given-names></name><etal>et al</etal>.</person-group>
<article-title>Broad conservation of milk utilization genes in <italic>Bifidobacterium longum</italic> subsp. <italic>infantis</italic> as revealed by comparative genomic hybridization</article-title>. <source/>Appl Environ Microbiol. <year>2010</year>;<volume>76</volume>:<fpage>7373</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="pmid">20802066</pub-id></mixed-citation>
</ref>
<ref id="bib89">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>LoCascio</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Ninonuevo</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Freeman</surname><given-names>SL</given-names></name><etal>et al</etal>.</person-group>
<article-title>Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation</article-title>. <source/>J Agric Food Chem. <year>2007</year>;<volume>55</volume>:<fpage>8914</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">17915960</pub-id></mixed-citation>
</ref>
<ref id="bib90">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>LoCascio</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Niñonuevo</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Kronewitter</surname><given-names>SR</given-names></name><etal>et al</etal>.</person-group>
<article-title>A versatile and scalable strategy for glycoprofiling bifidobacterial consumption of human milk oligosaccharides</article-title>. <source/>Microb Biotechnol. <year>2009</year>;<volume>2</volume>:<fpage>333</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">21261928</pub-id></mixed-citation>
</ref>
<ref id="bib91">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lucock</surname><given-names>M</given-names></name></person-group>
<article-title>Folic acid: nutritional biochemistry, molecular biology, and role in disease processes</article-title>. <source/>Mol Genet Metab. <year>2000</year>;<volume>71</volume>:<fpage>121</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">11001804</pub-id></mixed-citation>
</ref>
<ref id="bib93">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Makino</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kushiro</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ishikawa</surname><given-names>E</given-names></name><etal>et al</etal>.</person-group>
<article-title>Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant's microbiota</article-title>. <source/>PLoS One. <year>2013</year>;<volume>8</volume>:<fpage>e78331</fpage>.<pub-id pub-id-type="pmid">24244304</pub-id></mixed-citation>
</ref>
<ref id="bib94">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Makino</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ishikawa</surname><given-names>E</given-names></name><etal>et al</etal>.</person-group>
<article-title>Multilocus sequence typing of bifidobacterial strains from infant's faeces and human milk: are bifidobacteria being sustainably shared during breastfeeding?</article-title>
<source/>Benef Microbes. <year>2015</year>;<volume>6</volume>:<fpage>563</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">25691099</pub-id></mixed-citation>
</ref>
<ref id="bib92">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Makino</surname><given-names>H</given-names></name></person-group>
<article-title>Bifidobacterial strains in the intestines of newborns originate from their mothers</article-title>. <source/>Biosci microbiota, food Heal. <year>2018</year>;<volume>37</volume>:<fpage>79</fpage>–<lpage>85</lpage>.</mixed-citation>
</ref>
<ref id="bib95">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Makino</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yavuz</surname><given-names>AC</given-names></name><etal>et al</etal>.</person-group>
<article-title>Early-life events, including mode of delivery and type of feeding, siblings and gender, shape the developing gut microbiota</article-title>. <source/>PLoS One. <year>2016</year>;<volume>11</volume>:<fpage>e0158498</fpage>.<pub-id pub-id-type="pmid">27362264</pub-id></mixed-citation>
</ref>
<ref id="bib96">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Matsuki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yahagi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Mori</surname><given-names>H</given-names></name><etal>et al</etal>.</person-group>
<article-title>A key genetic factor for fucosyllactose utilization affects infant gut microbiota development</article-title>. <source/>Nat Commun. <year>2016</year>;<volume>7</volume>:<fpage>11939</fpage>.<pub-id pub-id-type="pmid">27340092</pub-id></mixed-citation>
</ref>
<ref id="bib97">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Meng</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Sommella</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Salviati</surname><given-names>E</given-names></name><etal>et al</etal>.</person-group>
<article-title>Indole-3-lactic acid, a metabolite of tryptophan, secreted by <italic>Bifidobacterium longum</italic> subspecies <italic>infantis</italic> is anti-inflammatory in the immature intestine</article-title>. <source/>Pediatr Res. <year>2020</year>:<fpage>1</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">32218540</pub-id></mixed-citation>
</ref>
<ref id="bib98">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Milani</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Duranti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lugli</surname><given-names>GA</given-names></name><etal>et al</etal>.</person-group>
<article-title>Comparative genomics of<italic>Bifidobacterium animalis</italic> subsp. <italic>lactis</italic> reveals a strict monophyletic bifidobacterial taxon</article-title>. <source/>Appl Environ Microbiol. <year>2013</year>;<volume>79</volume>:<fpage>4304</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">23645200</pub-id></mixed-citation>
</ref>
<ref id="bib100">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Milani</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lugli</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Duranti</surname><given-names>S</given-names></name><etal>et al</etal>.</person-group>
<article-title>Bifidobacteria exhibit social behavior through carbohydrate resource sharing in the gut</article-title>. <source/>Sci Rep. <year>2015a</year>;<volume>5</volume>:<fpage>15782</fpage>.<pub-id pub-id-type="pmid">26506949</pub-id></mixed-citation>
</ref>
<ref id="bib99">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Milani</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lugli</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Duranti</surname><given-names>S</given-names></name><etal>et al</etal>.</person-group>
<article-title>Genomic encyclopedia of type strains of the genus <italic>Bifidobacterium</italic></article-title>. <source/>Appl Environ Microbiol. <year>2014</year>;<volume>80</volume>:<fpage>6290</fpage>–<lpage>302</lpage>.<pub-id pub-id-type="pmid">25085493</pub-id></mixed-citation>
</ref>
<ref id="bib101">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Milani</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Mancabelli</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lugli</surname><given-names>GA</given-names></name><etal>et al</etal>.</person-group>
<article-title>Exploring vertical transmission of bifidobacteria from mother to child</article-title>. <source/>Appl Environ Microbiol. <year>2015b</year>;<volume>81</volume>:<fpage>7078</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="pmid">26231653</pub-id></mixed-citation>
</ref>
<ref id="bib102">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Milani</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Turroni</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Duranti</surname><given-names>S</given-names></name><etal>et al</etal>.</person-group>
<article-title>Genomics of the genus <italic>Bifidobacterium</italic> reveals species-specific adaptation to the glycan-rich gut environment</article-title>. <source/>Appl Environ Microbiol. <year>2016</year>;<volume>82</volume>:<fpage>980</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">26590291</pub-id></mixed-citation>
</ref>
<ref id="bib103">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Minami</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Odamaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hashikura</surname><given-names>N</given-names></name><etal>et al</etal>.</person-group>
<article-title>Lysozyme in breast milk is a selection factor for bifidobacterial colonisation in the infant intestine</article-title>. <source/>Benef Microbes. <year>2016</year>;<volume>7</volume>:<fpage>53</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">26503736</pub-id></mixed-citation>
</ref>
<ref id="bib104">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mitsuoka</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kaneuchi</surname><given-names>C</given-names></name></person-group>
<article-title>Ecology of the bifidobacteria</article-title>. <source/>Am J Clin Nutr. <year>1977</year>;<volume>30</volume>:<fpage>1799</fpage>–<lpage>810</lpage>.<pub-id pub-id-type="pmid">920640</pub-id></mixed-citation>
</ref>
<ref id="bib105">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Moeller</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Caro-Quintero</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mjungu</surname><given-names>D</given-names></name><etal>et al</etal>.</person-group>
<article-title>Cospeciation of gut microbiota with hominids</article-title>. <source/>Science (80-). <year>2016</year>;<volume>353</volume>:<fpage>380</fpage>–<lpage>2</lpage>.</mixed-citation>
</ref>
<ref id="bib106">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Motherway</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>Neirynck</surname><given-names>S</given-names></name><etal>et al</etal>.</person-group>
<article-title>Characterization of ApuB, an extracellular type II amylopullulanase from <italic>Bifidobacterium breve</italic> UCC2003</article-title>. <source/>Appl Environ Microbiol. <year>2008</year>;<volume>74</volume>:<fpage>6271</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">18689518</pub-id></mixed-citation>
</ref>
<ref id="bib107">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nishiyama</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Nagai</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Uribayashi</surname><given-names>K</given-names></name><etal>et al</etal>.</person-group>
<article-title>Two extracellular sialidases from <italic>Bifidobacterium bifidum</italic>promote the degradation of sialyl-oligosaccharides and support the growth of Bifidobacterium breve</article-title>. <source/>Anaerobe. <year>2018</year>;<volume>52</volume>:<fpage>22</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">29787815</pub-id></mixed-citation>
</ref>
<ref id="bib108">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>O'Callaghan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>van Sinderen</surname><given-names>D</given-names></name></person-group>
<article-title>Bifidobacteria and their role as members of the human gut microbiota</article-title>. <source/>Front Microbiol. <year>2016</year>;<volume>7</volume>:<fpage>925</fpage>.<pub-id pub-id-type="pmid">27379055</pub-id></mixed-citation>
</ref>
<ref id="bib109">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>O'Connell Motherway</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>van Sinderen</surname><given-names>D</given-names></name></person-group>
<article-title>Metabolism of a plant derived galactose‐containing polysaccharide by<italic>Bifidobacterium breve</italic> UCC2003</article-title>. <source/>Microb Biotechnol. <year>2011</year>;<volume>4</volume>:<fpage>403</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="pmid">21375716</pub-id></mixed-citation>
</ref>
<ref id="bib110">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>O'Connell Motherway</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kinsella</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname><given-names>GF</given-names></name><etal>et al</etal>.</person-group>
<article-title>Transcriptional and functional characterization of genetic elements involved in galacto‐oligosaccharide utilization by <italic>Bifidobacterium breve</italic>UCC 2003</article-title>. <source/>Microb Biotechnol. <year>2013</year>;<volume>6</volume>:<fpage>67</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="pmid">23199239</pub-id></mixed-citation>
</ref>
<ref id="bib111">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>O'Connell Motherway</surname><given-names>M</given-names></name>, <name name-style="western"><surname>O'Driscoll</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname><given-names>GF</given-names></name><etal>et al</etal>.</person-group>
<article-title>Overcoming the restriction barrier to plasmid transformation and targeted mutagenesis in<italic>Bifidobacterium breve</italic> UCC2003</article-title>. <source/>Microb Biotechnol. <year>2009</year>;<volume>2</volume>:<fpage>321</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">21261927</pub-id></mixed-citation>
</ref>
<ref id="bib112">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Odamaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Bottacini</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>K</given-names></name><etal>et al</etal>.</person-group>
<article-title>Genomic diversity and distribution of <italic>Bifidobacterium longum</italic>subsp. <italic>longum</italic> across the human lifespan</article-title>. <source/>Sci Rep. <year>2018</year>;<volume>8</volume>:<fpage>85</fpage>.<pub-id pub-id-type="pmid">29311585</pub-id></mixed-citation>
</ref>
<ref id="bib113">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Odamaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Bottacini</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Mitsuyama</surname><given-names>E</given-names></name><etal>et al</etal>.</person-group>
<article-title>Impact of a bathing tradition on shared gut microbe among Japanese families</article-title>. <source/>Sci Rep. <year>2019</year>;<volume>9</volume>:<fpage>1</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">30626917</pub-id></mixed-citation>
</ref>
<ref id="bib114">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Odamaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Horigome</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sugahara</surname><given-names>H</given-names></name><etal>et al</etal>.</person-group>
<article-title>Comparative genomics revealed genetic diversity and species/strain-level differences in carbohydrate metabolism of three probiotic bifidobacterial species</article-title>. <source/>Int J Genomics. <year>2015</year>;<volume>2015</volume>:<fpage>1</fpage>–<lpage>12</lpage>.</mixed-citation>
</ref>
<ref id="bib115">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Odamaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sugahara</surname><given-names>H</given-names></name><etal>et al</etal>.</person-group>
<article-title>Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study</article-title>. <source/>BMC Microbiol. <year>2016</year>;<volume>16</volume>:<fpage>90</fpage>.<pub-id pub-id-type="pmid">27220822</pub-id></mixed-citation>
</ref>
<ref id="bib116">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pacheco</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Barile</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Underwood</surname><given-names>MA</given-names></name><etal>et al</etal>.</person-group>
<article-title>The impact of the milk glycobiome on the neonate gut microbiota</article-title>. <source/>Annu Rev Anim Biosci. <year>2015</year>;<volume>3</volume>:<fpage>419</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="pmid">25387230</pub-id></mixed-citation>
</ref>
<ref id="bib117">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Parte</surname><given-names>AC</given-names></name></person-group>
<article-title>LPSN–List of Prokaryotic names with Standing in Nomenclature (bacterio. net), 20 years on</article-title>. <source/>Int J Syst Evol Microbiol. <year>2018</year>;<volume>68</volume>:<fpage>1825</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">29724269</pub-id></mixed-citation>
</ref>
<ref id="bib118">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Perez-Muñoz</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Arrieta</surname><given-names>M-C</given-names></name>, <name name-style="western"><surname>Ramer-Tait</surname><given-names>AE</given-names></name><etal>et al</etal>.</person-group>
<article-title>A critical assessment of the “sterile womb” and “in utero colonization” hypotheses: implications for research on the pioneer infant microbiome</article-title>. <source/>Microbiome. <year>2017</year>;<volume>5</volume>:<fpage>48</fpage>.<pub-id pub-id-type="pmid">28454555</pub-id></mixed-citation>
</ref>
<ref id="bib119">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pinto-Sánchez</surname><given-names>MI</given-names></name>, <name name-style="western"><surname>Smecuol</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Temprano</surname><given-names>MP</given-names></name><etal>et al</etal>.</person-group>
<article-title>
<italic>Bifidobacterium infantis</italic>NLS super strain reduces the expression of α-defensin-5, a marker of innate immunity, in the mucosa of active celiac disease patients</article-title>. <source/>J Clin Gastroenterol. <year>2017</year>;<volume>51</volume>:<fpage>814</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">27636409</pub-id></mixed-citation>
</ref>
<ref id="bib120">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pokusaeva</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>van Sinderen</surname><given-names>D</given-names></name></person-group>
<article-title>Carbohydrate metabolism in <italic>Bifidobacteria</italic></article-title>. <source/>Genes Nutr. <year>2011</year>;<volume>6</volume>:<fpage>285</fpage>–<lpage>306</lpage>.<pub-id pub-id-type="pmid">21484167</pub-id></mixed-citation>
</ref>
<ref id="bib121">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pokusaeva</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Neves</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Zomer</surname><given-names>A</given-names></name><etal>et al</etal>.</person-group>
<article-title>Ribose utilization by the human commensal <italic>Bifidobacterium breve</italic> UCC2003</article-title>. <source/>Microb Biotechnol. <year>2010</year>;<volume>3</volume>:<fpage>311</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">21255330</pub-id></mixed-citation>
</ref>
<ref id="bib123">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pokusaeva</surname><given-names>K</given-names></name>, <name name-style="western"><surname>O'Connell-Motherway</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zomer</surname><given-names>A</given-names></name><etal>et al</etal>.</person-group>
<article-title>Cellodextrin utilization by <italic>Bifidobacterium breve</italic> UCC2003</article-title>. <source/>Appl Environ Microbiol. <year>2011</year>;<volume>77</volume>:<fpage>1681</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">21216899</pub-id></mixed-citation>
</ref>
<ref id="bib122">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pokusaeva</surname><given-names>K</given-names></name>, <name name-style="western"><surname>O'Connell-Motherway</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zomer</surname><given-names>A</given-names></name><etal>et al</etal>.</person-group>
<article-title>Characterization of two novel α-glucosidases from <italic>Bifidobacterium breve</italic>UCC2003</article-title>. <source/>Appl Environ Microbiol. <year>2009</year>;<volume>75</volume>:<fpage>1135</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="pmid">19114534</pub-id></mixed-citation>
</ref>
<ref id="bib125">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pompei</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cordisco</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Amaretti</surname><given-names>A</given-names></name><etal>et al</etal>.</person-group>
<article-title>Administration of folate-producing bifidobacteria enhances folate status in Wistar rats</article-title>. <source/>J Nutr. <year>2007b</year>;<volume>137</volume>:<fpage>2742</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">18029493</pub-id></mixed-citation>
</ref>
<ref id="bib124">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pompei</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cordisco</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Amaretti</surname><given-names>A</given-names></name><etal>et al</etal>.</person-group>
<article-title>Folate production by bifidobacteria as a potential probiotic property</article-title>. <source/>Appl Environ Microbiol. <year>2007a</year>;<volume>73</volume>:<fpage>179</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">17071792</pub-id></mixed-citation>
</ref>
<ref id="bib126">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Prieur</surname><given-names>DJ</given-names></name></person-group>
<article-title>Tissue specific deficiency of lysozyme in ruminants</article-title>. <source/>Comp Biochem Physiol B. <year>1986</year>;<volume>85</volume>:<fpage>349</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">3780185</pub-id></mixed-citation>
</ref>
<ref id="bib127">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pruimboom</surname><given-names>L</given-names></name>, <name name-style="western"><surname>De Punder</surname><given-names>K</given-names></name></person-group>
<article-title>The opioid effects of gluten exorphins: asymptomatic celiac disease</article-title>. <source/>J Heal Popul Nutr. <year>2015</year>;<volume>33</volume>:<fpage>24</fpage>.</mixed-citation>
</ref>
<ref id="bib128">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Quagliariello</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Aloisio</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Bozzi Cionci</surname><given-names>N</given-names></name><etal>et al</etal>.</person-group>
<article-title>Effect of <italic>Bifidobacterium breve</italic>on the intestinal microbiota of coeliac children on a gluten free diet: a pilot study</article-title>. <source/>Nutrients. <year>2016</year>;<volume>8</volume>:<fpage>660</fpage>.</mixed-citation>
</ref>
<ref id="bib129">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rada</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Splichal</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Rockova</surname><given-names>S</given-names></name><etal>et al</etal>.</person-group>
<article-title>Susceptibility of bifidobacteria to lysozyme as a possible selection criterion for probiotic bifidobacterial strains</article-title>. <source/>Biotechnol Lett. <year>2010</year>;<volume>32</volume>:<fpage>451</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">19943182</pub-id></mixed-citation>
</ref>
<ref id="bib130">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rayburn</surname><given-names>WF</given-names></name>, <name name-style="western"><surname>Stanley</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Garrett</surname><given-names>ME</given-names></name></person-group>
<article-title>Periconceptional folate intake and neural tube defects</article-title>. <source/>J Am Coll Nutr. <year>1996</year>;<volume>15</volume>:<fpage>121</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">8778140</pub-id></mixed-citation>
</ref>
<ref id="bib131">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Reyman</surname><given-names>M</given-names></name>, <name name-style="western"><surname>van Houten</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>van Baarle</surname><given-names>D</given-names></name><etal>et al</etal>.</person-group>
<article-title>Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life</article-title>. <source/>Nat Commun. <year>2019</year>;<volume>10</volume>:<fpage>1</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">30602773</pub-id></mixed-citation>
</ref>
<ref id="bib132">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rivière</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Moens</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Selak</surname><given-names>M</given-names></name><etal>et al</etal>.</person-group>
<article-title>The ability of bifidobacteria to degrade arabinoxylan oligosaccharide constituents and derived oligosaccharides is strain dependent</article-title>. <source/>Appl Environ Microbiol. <year>2014</year>;<volume>80</volume>:<fpage>204</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">24141124</pub-id></mixed-citation>
</ref>
<ref id="bib133">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rockova</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rada</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Nevoral</surname><given-names>J</given-names></name><etal>et al</etal>.</person-group>
<article-title>Inter-species differences in the growth of bifidobacteria cultured on human milk oligosaccharides</article-title>. <source/>Folia Microbiol (Praha). <year>2012</year>;<volume>57</volume>:<fpage>321</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">22491988</pub-id></mixed-citation>
</ref>
<ref id="bib134">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rodriguez</surname><given-names>CI</given-names></name>, <name name-style="western"><surname>Martiny</surname><given-names>JBH</given-names></name></person-group>
<article-title>Evolutionary relationships among bifidobacteria and their hosts and environments</article-title>. <source/>BMC Genomics. <year>2020</year>;<volume>21</volume>:<fpage>1</fpage>–<lpage>12</lpage>.</mixed-citation>
</ref>
<ref id="bib135">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rossi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Amaretti</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Raimondi</surname><given-names>S</given-names></name></person-group>
<article-title>Folate production by probiotic bacteria</article-title>. <source/>Nutrients. <year>2011</year>;<volume>3</volume>:<fpage>118</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">22254078</pub-id></mixed-citation>
</ref>
<ref id="bib136">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ruas-Madiedo</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gueimonde</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fernández-García</surname><given-names>M</given-names></name><etal>et al</etal>.</person-group>
<article-title>Mucin degradation by <italic>Bifidobacterium</italic> strains isolated from the human intestinal microbiota</article-title>. <source/>Appl Environ Microbiol. <year>2008</year>;<volume>74</volume>:<fpage>1936</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">18223105</pub-id></mixed-citation>
</ref>
<ref id="bib137">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ruiz-Moyano</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Totten</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Garrido</surname><given-names>DA</given-names></name><etal>et al</etal>.</person-group>
<article-title>Variation in consumption of human milk oligosaccharides by infant gut-associated strains of<italic>Bifidobacterium breve</italic></article-title>. <source/>Appl Environ Microbiol. <year>2013</year>;<volume>79</volume>:<fpage>6040</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">23892749</pub-id></mixed-citation>
</ref>
<ref id="bib138">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ruiz</surname><given-names>L</given-names></name>, <name name-style="western"><surname>García-Carral</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rodriguez</surname><given-names>JM</given-names></name></person-group>
<article-title>Unfolding the human milk microbiome landscape in the omics era</article-title>. <source/>Front Microbiol. <year>2019</year>;<volume>10</volume>:<fpage>1</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">30728808</pub-id></mixed-citation>
</ref>
<ref id="bib140">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Russell</surname><given-names>WR</given-names></name>, <name name-style="western"><surname>Duncan</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Scobbie</surname><given-names>L</given-names></name><etal>et al</etal>.</person-group>
<article-title>Major phenylpropanoid‐derived metabolites in the human gut can arise from microbial fermentation of protein</article-title>. <source/>Mol Nutr Food Res. <year>2013</year>;<volume>57</volume>:<fpage>523</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="pmid">23349065</pub-id></mixed-citation>
</ref>
<ref id="bib141">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rutayisire</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><etal>et al</etal>.</person-group>
<article-title>The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants’ life: a systematic review</article-title>. <source/>BMC Gastroenterol. <year>2016</year>;<volume>16</volume>:<fpage>86</fpage>.<pub-id pub-id-type="pmid">27475754</pub-id></mixed-citation>
</ref>
<ref id="bib142">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rutherfurd-Markwick</surname><given-names>KJ</given-names></name></person-group>
<article-title>Food proteins as a source of bioactive peptides with diverse functions</article-title>. <source/>Br J Nutr. <year>2012</year>;<volume>108</volume>:<fpage>S149</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">23107526</pub-id></mixed-citation>
</ref>
<ref id="bib144">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ryan</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>van Sinderen</surname><given-names>D</given-names></name></person-group>
<article-title>Screening for and identification of starch-, amylopectin-, and pullulan-degrading activities in bifidobacterial strains</article-title>. <source/>Appl Environ Microbiol. <year>2006</year>;<volume>72</volume>:<fpage>5289</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="pmid">16885278</pub-id></mixed-citation>
</ref>
<ref id="bib143">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ryan</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname><given-names>GF</given-names></name>, <name name-style="western"><surname>van Sinderen</surname><given-names>D</given-names></name></person-group>
<article-title>Transcriptional regulation and characterization of a novel β-fructofuranosidase-encoding gene from <italic>Bifidobacterium breve</italic>UCC2003</article-title>. <source/>Appl Environ Microbiol. <year>2005</year>;<volume>71</volume>:<fpage>3475</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="pmid">16000751</pub-id></mixed-citation>
</ref>
<ref id="bib145">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sakanaka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gotoh</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>K</given-names></name><etal>et al</etal>.</person-group>
<article-title>Varied Pathways of Infant Gut-Associated Bifidobacterium to Assimilate Human Milk Oligosaccharides: Prevalence of the Gene Set and Its Correlation with Bifidobacteria-Rich Microbiota Formation</article-title>. <source/>Nutrients. <year>2020</year>;<volume>12</volume>:<fpage>71</fpage>.</mixed-citation>
</ref>
<ref id="bib146">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sakanaka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hansen</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Gotoh</surname><given-names>A</given-names></name><etal>et al</etal>.</person-group>
<article-title>Evolutionary adaptation in fucosyllactose uptake systems supports bifidobacteria-infant symbiosis</article-title>. <source/>Sci Adv. <year>2019</year>;<volume>5</volume>:<fpage>eaaw7696</fpage>.<pub-id pub-id-type="pmid">31489370</pub-id></mixed-citation>
</ref>
<ref id="bib147">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sakurai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hashikura</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Minami</surname><given-names>J</given-names></name><etal>et al</etal>.</person-group>
<article-title>Tolerance mechanisms of human-residential bifidobacteria against lysozyme</article-title>. <source/>Anaerobe. <year>2017</year>;<volume>47</volume>:<fpage>104</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">28478277</pub-id></mixed-citation>
</ref>
<ref id="bib148">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sakurai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Odamaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>J</given-names></name></person-group>
<article-title>Production of Indole-3-Lactic Acid by Bifidobacterium Strains Isolated fromHuman Infants</article-title>. <source/>Microorganisms. <year>2019</year>;<volume>7</volume>:<fpage>340</fpage>.</mixed-citation>
</ref>
<ref id="bib149">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sakurai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yamada</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hashikura</surname><given-names>N</given-names></name><etal>et al</etal>.</person-group>
<article-title>Degradation of food-derived opioid peptides by bifidobacteria</article-title>. <source/>Benef Microbes. <year>2018</year>;<volume>9</volume>:<fpage>675</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="pmid">29633643</pub-id></mixed-citation>
</ref>
<ref id="bib150">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sakurama</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kiyohara</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wada</surname><given-names>J</given-names></name><etal>et al</etal>.</person-group>
<article-title>Lacto-N-biosidase encoded by a novel gene of Bifidobacterium longum subspecies longum shows unique substrate specificity and requires a designated chaperone for its active expression</article-title>. <source/>J Biol Chem. <year>2013</year>;<volume>288</volume>:<fpage>25194</fpage>–<lpage>206</lpage>.<pub-id pub-id-type="pmid">23843461</pub-id></mixed-citation>
</ref>
<ref id="bib151">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schell</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Karmirantzou</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Snel</surname><given-names>B</given-names></name><etal>et al</etal>.</person-group>
<article-title>The genome sequence of <italic>Bifidobacterium longum</italic> reflects its adaptation to the human gastrointestinal tract</article-title>. <source/>Proc Natl Acad Sci. <year>2002</year>;<volume>99</volume>:<fpage>14422</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">12381787</pub-id></mixed-citation>
</ref>
<ref id="bib152">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sela</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Chapman</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Adeuya</surname><given-names>A</given-names></name><etal>et al</etal>.</person-group>
<article-title>The genome sequence of <italic>Bifidobacterium longum</italic>subsp. <italic>infantis</italic> reveals adaptations for milk utilization within the infant microbiome</article-title>. <source/>Proc Natl Acad Sci. <year>2008</year>;<volume>105</volume>:<fpage>18964</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">19033196</pub-id></mixed-citation>
</ref>
<ref id="bib153">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sela</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Garrido</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Lerno</surname><given-names>L</given-names></name><etal>et al</etal>.</person-group>
<article-title>
<italic>Bifidobacterium longum</italic> subsp. <italic>infantis</italic> ATCC 15697 α-fucosidases are active on fucosylated human milk oligosaccharides</article-title>. <source/>Appl Environ Microbiol. <year>2012</year>;<volume>78</volume>:<fpage>795</fpage>–<lpage>803</lpage>.<pub-id pub-id-type="pmid">22138995</pub-id></mixed-citation>
</ref>
<ref id="bib154">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sela</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Mills</surname><given-names>DA</given-names></name></person-group>
<article-title>Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides</article-title>. <source/>Trends Microbiol. <year>2010</year>;<volume>18</volume>:<fpage>298</fpage>–<lpage>307</lpage>.<pub-id pub-id-type="pmid">20409714</pub-id></mixed-citation>
</ref>
<ref id="bib155">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Serena</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Camhi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sturgeon</surname><given-names>C</given-names></name><etal>et al</etal>.</person-group>
<article-title>The role of gluten in celiac disease and type 1 diabetes</article-title>. <source/>Nutrients. <year>2015</year>;<volume>7</volume>:<fpage>7143</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">26343710</pub-id></mixed-citation>
</ref>
<ref id="bib156">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shigeno</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Banno</surname><given-names>T</given-names></name><etal>et al</etal>.</person-group>
<article-title>Gut microbiota development in mice is affected by hydrogen peroxide produced from amino acid metabolism during lactation</article-title>. <source/>FASEB J. <year>2018</year>;<volume>33</volume>:<fpage>3343</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">30433825</pub-id></mixed-citation>
</ref>
<ref id="bib157">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Smecuol</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hwang</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Sugai</surname><given-names>E</given-names></name><etal>et al</etal>.</person-group>
<article-title>Exploratory, randomized, double-blind, placebo-controlled study on the effects of <italic>Bifidobacterium infantis</italic> natren life start strain super strain in active celiac disease</article-title>. <source/>J Clin Gastroenterol. <year>2013</year>;<volume>47</volume>:<fpage>139</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="pmid">23314670</pub-id></mixed-citation>
</ref>
<ref id="bib158">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sokolov</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Kost</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Andreeva</surname><given-names>O</given-names></name><etal>et al</etal>.</person-group>
<article-title>Autistic children display elevated urine levels of bovine casomorphin-7 immunoreactivity</article-title>. <source/>Peptides. <year>2014</year>;<volume>56</volume>:<fpage>68</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">24657283</pub-id></mixed-citation>
</ref>
<ref id="bib159">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Stanger</surname><given-names>O</given-names></name></person-group>
<article-title>Physiology of folic acid in health and disease</article-title>. <source/>Curr Drug Metab. <year>2002</year>;<volume>3</volume>:<fpage>211</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">12003352</pub-id></mixed-citation>
</ref>
<ref id="bib160">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Stephen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Alles</surname><given-names>M</given-names></name>, <name name-style="western"><surname>De Graaf</surname><given-names>C</given-names></name><etal>et al</etal>.</person-group>
<article-title>The role and requirements of digestible dietary carbohydrates in infants and toddlers</article-title>. <source/>Eur J Clin Nutr. <year>2012</year>;<volume>66</volume>:<fpage>765</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="pmid">22473042</pub-id></mixed-citation>
</ref>
<ref id="bib161">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Strozzi</surname><given-names>GP</given-names></name>, <name name-style="western"><surname>Mogna</surname><given-names>L</given-names></name></person-group>
<article-title>Quantification of folic acid in human feces after administration of <italic>Bifidobacterium</italic> probiotic strains</article-title>. <source/>J Clin Gastroenterol. <year>2008</year>;<volume>42</volume>:<fpage>S179</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">18685499</pub-id></mixed-citation>
</ref>
<ref id="bib162">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sugahara</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Odamaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hashikura</surname><given-names>N</given-names></name><etal>et al</etal>.</person-group>
<article-title>Differences in folate production by bifidobacteria of different origins</article-title>. <source/>Biosci microbiota, food Heal. <year>2015</year>;<volume>34</volume>:<fpage>87</fpage>–<lpage>93</lpage>.</mixed-citation>
</ref>
<ref id="bib163">
<mixed-citation publication-type="other">
<person-group person-group-type="author"><name name-style="western"><surname>Sugahara</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Odamaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>J</given-names></name></person-group>
<article-title>Genotypic and phenotypic evaluation revealed the appropriateness of human-residential bifidobacteria for human use</article-title>. <year>2015</year>.</mixed-citation>
</ref>
<ref id="bib164">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>C</given-names></name><etal>et al</etal>.</person-group>
<article-title>Comparative genomic analysis of 45 type strains of the genus <italic>Bifidobacterium</italic>: a snapshot of its genetic diversity and evolution</article-title>. <source/>PLoS One. <year>2015</year>;<volume>10</volume>:<fpage>1</fpage>–<lpage>14</lpage>.</mixed-citation>
</ref>
<ref id="bib165">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><etal>et al</etal>.</person-group>
<article-title>Relation of β-casomorphin to apnea in sudden infant death syndrome</article-title>. <source/>Peptides. <year>2003</year>;<volume>24</volume>:<fpage>937</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="pmid">12948848</pub-id></mixed-citation>
</ref>
<ref id="bib166">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wada</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Katayama</surname><given-names>T</given-names></name><etal>et al</etal>.</person-group>
<article-title>Structural and thermodynamic analyses of solute-binding protein from <italic>Bifidobacterium longum</italic>specific for core 1 disaccharide and lacto-N-biose I</article-title>. <source/>J Biol Chem. <year>2008</year>;<volume>283</volume>:<fpage>13165</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">18332142</pub-id></mixed-citation>
</ref>
<ref id="bib167">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kosaka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shindo</surname><given-names>K</given-names></name><etal>et al</etal>.</person-group>
<article-title>Identification of antioxidants produced by <italic>Lactobacillus plantarum</italic></article-title>. <source/>Biosci Biotechnol Biochem. <year>2013</year>:<fpage>121006</fpage>.</mixed-citation>
</ref>
<ref id="bib168">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tailford</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Crost</surname><given-names>EH</given-names></name>, <name name-style="western"><surname>Kavanaugh</surname><given-names>D</given-names></name><etal>et al</etal>.</person-group>
<article-title>Mucin glycan foraging in the human gut microbiome</article-title>. <source/>Front Genet. <year>2015</year>;<volume>6</volume>:<fpage>81</fpage>.<pub-id pub-id-type="pmid">25852737</pub-id></mixed-citation>
</ref>
<ref id="bib169">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tannock</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>Lawley</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Munro</surname><given-names>K</given-names></name><etal>et al</etal>.</person-group>
<article-title>Comparison of the compositions of the stool microbiotas of infants fed goat milk formula, cow milk-based formula, or breast milk</article-title>. <source/>Appl Environ Microbiol. <year>2013</year>;<volume>79</volume>:<fpage>3040</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">23455335</pub-id></mixed-citation>
</ref>
<ref id="bib170">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Teschemacher</surname><given-names>H</given-names></name></person-group>
<article-title>Opioid receptor ligands derived from food proteins</article-title>. <source/>Curr Pharm Des. <year>2003</year>;<volume>9</volume>:<fpage>1331</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">12769741</pub-id></mixed-citation>
</ref>
<ref id="bib171">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Thomson</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Medina</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Garrido</surname><given-names>D</given-names></name></person-group>
<article-title>Human milk oligosaccharides and infant gut bifidobacteria: molecular strategies for their utilization</article-title>. <source/>Food Microbiol. <year>2018</year>;<volume>75</volume>:<fpage>37</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="pmid">30056961</pub-id></mixed-citation>
</ref>
<ref id="bib172">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Toda</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hisata</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Satoh</surname><given-names>T</given-names></name><etal>et al</etal>.</person-group>
<article-title>Neonatal oral fluid as a transmission route for bifidobacteria to the infant gut immediately after birth</article-title>. <source/>Sci Rep. <year>2019</year>;<volume>9</volume>:<fpage>8692</fpage>.<pub-id pub-id-type="pmid">31213639</pub-id></mixed-citation>
</ref>
<ref id="bib173">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Torres-Alipi</surname><given-names>BI</given-names></name>, <name name-style="western"><surname>Fragoso-Ramírez</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Martínez-Limón</surname><given-names>AJ</given-names></name><etal>et al</etal>.</person-group>
<article-title>Bacterial colonization of the oral cavity in the newborn</article-title>. <source/>Bol Med Hosp Infant Mex. <year>1990</year>;<volume>47</volume>:<fpage>78</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">2337468</pub-id></mixed-citation>
</ref>
<ref id="bib174">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tremaroli</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Bäckhed</surname><given-names>F</given-names></name></person-group>
<article-title>Functional interactions between the gut microbiota and host metabolism</article-title>. <source/>Nature. <year>2012</year>;<volume>489</volume>:<fpage>242</fpage>.<pub-id pub-id-type="pmid">22972297</pub-id></mixed-citation>
</ref>
<ref id="bib175">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Turroni</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Bottacini</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Foroni</surname><given-names>E</given-names></name><etal>et al</etal>.</person-group>
<article-title>Genome analysis of <italic>Bifidobacterium bifidum</italic> PRL2010 reveals metabolic pathways for host-derived glycan foraging</article-title>. <source/>Proc Natl Acad Sci. <year>2010</year>;<volume>107</volume>:<fpage>19514</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">20974960</pub-id></mixed-citation>
</ref>
<ref id="bib176">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Turroni</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Duranti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Milani</surname><given-names>C</given-names></name><etal>et al</etal>.</person-group>
<article-title>Bifidobacterium bifidum: A Key Member of the Early Human Gut Microbiota</article-title>. <source/>Microorganisms. <year>2019</year>;<volume>7</volume>:<fpage>544</fpage>.</mixed-citation>
</ref>
<ref id="bib177">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Turroni</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Foroni</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Pizzetti</surname><given-names>P</given-names></name><etal>et al</etal>.</person-group>
<article-title>Exploring the diversity of the bifidobacterial population in the human intestinal tract</article-title>. <source/>Appl Environ Microbiol. <year>2009</year>;<volume>75</volume>:<fpage>1534</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="pmid">19168652</pub-id></mixed-citation>
</ref>
<ref id="bib178">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Turroni</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Peano</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pass</surname><given-names>DA</given-names></name><etal>et al</etal>.</person-group>
<article-title>Diversity of bifidobacteria within the infant gut microbiota</article-title>. <source/>PLoS One. <year>2012</year>;<volume>7</volume>:<fpage>e36957</fpage>.<pub-id pub-id-type="pmid">22606315</pub-id></mixed-citation>
</ref>
<ref id="bib179">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Turroni</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ribbera</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Foroni</surname><given-names>E</given-names></name><etal>et al</etal>.</person-group>
<article-title>Human gut microbiota and bifidobacteria: from composition to functionality</article-title>. <source/>Antonie Van Leeuwenhoek. <year>2008</year>;<volume>94</volume>:<fpage>35</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">18338233</pub-id></mixed-citation>
</ref>
<ref id="bib180">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Turroni</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Van Sinderen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ventura</surname><given-names>M</given-names></name></person-group>
<article-title>Genomics and ecological overview of the genus <italic>Bifidobacterium</italic></article-title>. <source/>Int J Food Microbiol. <year>2011</year>;<volume>149</volume>:<fpage>37</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">21276626</pub-id></mixed-citation>
</ref>
<ref id="bib181">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Underwood</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Kalanetra</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Bokulich</surname><given-names>NA</given-names></name><etal>et al</etal>.</person-group>
<article-title>A comparison of two probiotic strains of bifidobacteria in premature infants</article-title>. <source/>J Pediatr. <year>2013</year>;<volume>163</volume>:<fpage>1585</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">23993139</pub-id></mixed-citation>
</ref>
<ref id="bib182">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ventura</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Canchaya</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tauch</surname><given-names>A</given-names></name><etal>et al</etal>.</person-group>
<article-title>Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylum</article-title>. <source/>Microbiol Mol Biol Rev. <year>2007</year>;<volume>71</volume>:<fpage>495</fpage>–<lpage>548</lpage>.<pub-id pub-id-type="pmid">17804669</pub-id></mixed-citation>
</ref>
<ref id="bib183">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ventura</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Turroni</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lugli</surname><given-names>GA</given-names></name><etal>et al</etal>.</person-group>
<article-title>Bifidobacteria and humans: our special friends, from ecological to genomics perspectives</article-title>. <source/>J Sci Food Agric. <year>2014</year>;<volume>94</volume>:<fpage>163</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">23963950</pub-id></mixed-citation>
</ref>
<ref id="bib184">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ventura</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Turroni</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zomer</surname><given-names>A</given-names></name><etal>et al</etal>.</person-group>
<article-title>The <italic>Bifidobacterium dentium</italic> Bd1 genome sequence reflects its genetic adaptation to the human oral cavity</article-title>. <source/>PLos Genet. <year>2009</year>;<volume>5</volume>:<fpage>e1000785</fpage>.<pub-id pub-id-type="pmid">20041198</pub-id></mixed-citation>
</ref>
<ref id="bib185">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wada</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ando</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kiyohara</surname><given-names>M</given-names></name><etal>et al</etal>.</person-group>
<article-title>
<italic>Bifidobacterium bifidum</italic> lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure</article-title>. <source/>Appl Environ Microbiol. <year>2008</year>;<volume>74</volume>:<fpage>3996</fpage>–<lpage>4004</lpage>.<pub-id pub-id-type="pmid">18469123</pub-id></mixed-citation>
</ref>
<ref id="bib186">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>S</given-names></name><etal>et al</etal>.</person-group>
<article-title>Fecal microbiota composition of breast-fed infants is correlated with human milk oligosaccharides consumed</article-title>. <source/>J Pediatr Gastroenterol Nutr. <year>2015</year>;<volume>60</volume>:<fpage>825</fpage>.<pub-id pub-id-type="pmid">25651488</pub-id></mixed-citation>
</ref>
<ref id="bib187">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wasilewska</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sienkiewicz-Szłapka</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kuźbida</surname><given-names>E</given-names></name><etal>et al</etal>.</person-group>
<article-title>The exogenous opioid peptides and DPPIV serum activity in infants with apnoea expressed as apparent life threatening events (ALTE)</article-title>. <source/>Neuropeptides. <year>2011</year>;<volume>45</volume>:<fpage>189</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="pmid">21334743</pub-id></mixed-citation>
</ref>
<ref id="bib188">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Watanabe</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Makino</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sasamoto</surname><given-names>M</given-names></name><etal>et al</etal>.</person-group>
<article-title>Bifidobacterium mongoliense sp. nov., from airag, a traditional fermented mare's milk product from Mongolia</article-title>. <source/>Int J Syst Evol Microbiol. <year>2009</year>;<volume>59</volume>:<fpage>1535</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">19502349</pub-id></mixed-citation>
</ref>
<ref id="bib189">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wilck</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Matus</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Kearney</surname><given-names>SM</given-names></name><etal>et al</etal>.</person-group>
<article-title>Salt-responsive gut commensal modulates TH17 axis and disease</article-title>. <source/>Nature. <year>2017</year>;<volume>551</volume>:<fpage>585</fpage>.<pub-id pub-id-type="pmid">29143823</pub-id></mixed-citation>
</ref>
<ref id="bib190">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Sugahara</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Odamaki</surname><given-names>T</given-names></name><etal>et al</etal>.</person-group>
<article-title>Different physiological properties of human-residential and non-human-residential bifidobacteria in human health</article-title>. <source/>Benef Microbes. <year>2018</year>;<volume>9</volume>
<comment>DOI: 10.3920/BM2017.0031</comment>.</mixed-citation>
</ref>
<ref id="bib191">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Tanaka</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kuhara</surname><given-names>T</given-names></name><etal>et al</etal>.</person-group>
<article-title>Potential Effects of Indole-3-Lactic Acid, a Metabolite of Human Bifidobacteria, on NGF-induced Neurite Outgrowth in PC12 Cells</article-title>. <source/>Microorganisms. <year>2020</year>;<volume>8</volume>:<fpage>398</fpage>.</mixed-citation>
</ref>
<ref id="bib192">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nishimoto</surname><given-names>M</given-names></name><etal>et al</etal>.</person-group>
<article-title>Distribution of in vitro fermentation ability of lacto-N-biose I, a major building block of human milk oligosaccharides, in bifidobacterial strains</article-title>. <source/>Appl Environ Microbiol. <year>2010a</year>;<volume>76</volume>:<fpage>54</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">19854932</pub-id></mixed-citation>
</ref>
<ref id="bib193">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Odamaki</surname><given-names>T</given-names></name><etal>et al</etal>.</person-group>
<article-title>Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market</article-title>. <source/>Biosci Biotechnol Biochem. <year>2010b</year>;<volume>74</volume>:<fpage>336</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">20139616</pub-id></mixed-citation>
</ref>
<ref id="bib194">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gotoh</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sakanaka</surname><given-names>M</given-names></name><etal>et al</etal>.</person-group>
<article-title>Molecular insight into evolution of symbiosis between breast-fed infants and a member of the human gut microbiome <italic>Bifidobacterium</italic><italic>longum</italic></article-title>. <source/>Cell Chem Biol. <year>2017</year>;<volume>24</volume>:<fpage>515</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">28392148</pub-id></mixed-citation>
</ref>
<ref id="bib195">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yatsunenko</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Rey</surname><given-names>FE</given-names></name>, <name name-style="western"><surname>Manary</surname><given-names>MJ</given-names></name><etal>et al</etal>.</person-group>
<article-title>Human gut microbiome viewed across age and geography</article-title>. <source/>Nature. <year>2012</year>;<volume>486</volume>:<fpage>222</fpage>.<pub-id pub-id-type="pmid">22699611</pub-id></mixed-citation>
</ref>
<ref id="bib196">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zou</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xue</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>G</given-names></name><etal>et al</etal>.</person-group>
<article-title>1,520 reference genomes from cultivated human gut bacteria enable functional microbiome analyses</article-title>. <source/>Nat Biotechnol. <year>2019</year>;<volume>37</volume>:<fpage>179</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">30718868</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>